+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Get PDF Full Texts from EurekaMag Chapter 46879

Chapter 46879 provides scholary research titles of which PDF Full Texts are available through EurekaMag.





Cray, S.H.; Dixon, J.L.; Heard, C.M.; Selsby, D.S., 1996:
Oral midazolam premedication for paediatric day case patients

Rosenberg, M., 2001:
Oral midazolam syrup for sedation in pediatric dentistry

Dionne, R., 2001:
Oral midazolam syrup: a safer alternative for pediatric sedation

Lammers, C.R.; Rosner, J.L.; Crockett, D.E.; Chhokra, R.; Brock-Utne, J.G., 2002:
Oral midazolam with an antacid may increase the speed of onset of sedation in children prior to general anaesthesia

Nathan, J.E.; Vargas, K.G., 2002:
Oral midazolam with and without meperidine for management of the difficult young pediatric dental patient: a retrospective study

Goho, C., 2001:
Oral midazolam-grapefruit juice drug interaction

Smith, B.M.; Cutilli, B.J.; Saunders, W., 1998:
Oral midazolam: pediatric conscious sedation

Anonymous, 1998:
Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. An open multicenter study. UK Multicenter Study Group

Anonymous, 1998 :
Oral migraine drug approved for marketing

Anonymous, 1998:
Oral migraine treatment approved

Mohan, A.; Seth, S., 2000:
Oral miltefosine in the treatment of kala-azar

Katayama, I.; Yokozeki, H.; Nishioka, K., 1994:
Oral minocycline improved keratosis follicularis squamosa (Dohi) and related disorder: bacterial factors are possibly involved in abberant keratinization

Ngai, S.W.; Chan, Y.M.; Liu, K.L.; Ho, P.C., 1998:
Oral misoprostol for cervical priming in non-pregnant women

Alfirevic, Z.; Howarth, G.; Gaussmann, A., 2000:
Oral misoprostol for induction of labour with a viable fetus

Hoffmann, R.A.; Anthony, J.; Fawcus, S., 2001:
Oral misoprostol vs. placebo in the management of prelabor rupture of membranes at term

Maspero, J.F.; Dueñas-Meza, E.; Volovitz, B.; Pinacho Daza, C.; Kosa, L.; Vrijens, F.; Leff, J.A., 2002:
Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy

Brestel, E.P., 2000:
Oral montelukast versus inhaled salmeterol to prevent exercise-induced bonchonconstriction

Malmstrom, K.; Rodriguez-Gomez, G.; Guerra, J.; Villaran, C.; Piñeiro, A.; Wei, L.X.; Seidenberg, B.C.; Reiss, T.F., 1999:
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

Anonymous, 1996:
Oral morphine eases chronic non-cancer pain, with little risk of addiction

Conti, C.; Tso, E.; Browne, B., 1996:
Oral morphine protocol for sickle cell crisis pain

Anonymous, 1996:
Oral morphine termed narcotic standard in severe cancer pain

Haruki, T.; Kanomi, R.; Morita, H.; Kawabata, J., 1995:
Oral morphology and tongue habits

Trauner, D.A.; Fahmy, R.F.; Mishler, D.A., 2001:
Oral motor dysfunction and feeding difficulties in nephropathic cystinosis

Vargus-Adams, J., 2002:
Oral motor dysfunction in nephropathic cystinosis

Winocur, E.; Gavish, A.; Volfin, G.; Halachmi, M.; Gazit, E., 2002:
Oral motor parafunctions among heavy drug addicts and their effects on signs and symptoms of temporomandibular disorders

Yokochi, K., 1998:
Oral motor patterns during feeding in severely physically disabled children

Vaillant, L.; Jan, V.; Hüttenberger, B., 1999:
Oral mucosa ulcerations

Seoane Leston, J.M.; Aguado Santos, A.; Varela-Centelles, P.I.; Vazquez Garcia, J.; Romero, M.A.; Pias Villamor, L., 2002:
Oral mucosa: variations from normalcy, part I

Leston, J.M.Seoane.; Santos, A.Aguado.; Varela-Centelles, P.I.; Garcia, J.Vazquez.; Romero, M.A.; Villamor, L.Pias., 2002:
Oral mucosa: variations from normalcy, part II

Svensson, P.; Arendt-Nielsen, L.; Bjerring, P.; Kaaber, S., 1993:
Oral mucosal analgesia quantitatively assessed by argon laser-induced thresholds and single-evoked vertex potentials

Golden, D.P.; Hooley, J.R., 1994:
Oral mucosal biopsy procedures. Excisional and incisional

Heckmann, J.G.; Hilz, M.J.; Hummel, T.; Popp, M.; Marthol, H.; Neundörfer, B.; Heckmann, S.M., 2001:
Oral mucosal blood flow following dry ice stimulation in humans

Kim, T-Won.; Chen, Q.; Shen, X.; Regezi, J.A.; Ramos, D.M.; Tanaka, H.; Jordan, R.C.K.; Kramer, R.H., 2003:
Oral mucosal carcinogenesis in SENCAR mice

Zedler, C.; Zedler-Spéhler, D.; Nadal, D.; van Waes, H., 1996:
Oral mucosal changes in children. The clinical picture and therapy of selected pediatric diseases

Axéll, T.E., 1993:
Oral mucosal changes related to smokeless tobacco usage: research findings in Scandinavia

Qiu, H.; Liu, Y.; Bai, S.; Li, C.; Feng, M., 2002:
Oral mucosal conditions and some related factors in 140 Uygur centenarians

Jainkittivong, A.; Aneksuk, V.; Langlais, R.P., 2002:
Oral mucosal conditions in elderly dental patients

Herlofson, B.B.; Barkvoll, P., 1996:
Oral mucosal desquamation of pre- and post-menopausal women. A comparison of response to sodium lauryl sulphate in toothpastes

Scully, C.; Porter, S.R., 1994:
Oral mucosal disease: a decade of new entities, aetiologies and associations

Winning, T.A.; Townsend, G.C., 2001:
Oral mucosal embryology and histology

Challacombe, S.J.; Sweet, S.P., 2002:
Oral mucosal immunity and HIV infection: current status

Little, M.C.; Griffiths, C.E.M.; Watson, R.E.B.; Pemberton, M.N.; Thornhill, M.H., 2003:
Oral mucosal keratinocytes express RANTES and ICAM-1, but not interleukin-8, in oral lichen planus and oral lichenoid reactions induced by amalgam fillings

Evans, W.W.; Pogrel, M.A.; Regezi, J.A., 1996:
Oral mucosal lesion associated with sickle cell disease

Zain, R.B.; Ikeda, N.; Gupta, P.C.; Warnakulasuriya, S.; van Wyk, C.W.; Shrestha, P.; Axéll, T., 1999:
Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996

Rivera-Hidalgo, F.; Stanford, T.W., 1999:
Oral mucosal lesions caused by infective microorganisms. I. Viruses and bacteria

Stanford, T.W.; Rivera-Hidalgo, F., 1999:
Oral mucosal lesions caused by infective microorganisms. II. Fungi and parasites

Landells, I.D.; Prendiville, J.S., 1994:
Oral mucosal lesions in a Somali boy

Reichart, P.A., 2000:
Oral mucosal lesions in a representative cross-sectional study of aging Germans

Baliga, A.M.; Brave, V.R.; Vyas, H.A., 1995:
Oral mucosal lesions in patients with acute leukemias and related disorders due to cytotoxic therapy

Alam, F.; Hamburger, J., 2001:
Oral mucosal lichen planus in children

Bronny, A.T.; Thies, R.M., 1990:
Oral mucosal lichenoid reaction to sulfamethoxazole

Hicks, M.J.; Flaitz, C.M., 2000:
Oral mucosal melanoma: epidemiology and pathobiology

Barker, B.F.; Carpenter, W.M.; Daniels, T.E.; Kahn, M.A.; Leider, A.S.; Lozada-Nur, F.; Lynch, D.P.; Melrose, R.; Merrell, P.; Morton, T.; Peters, E.; Regezi, J.A.; Richards, S.D.; Rick, G.M.; Rohrer, M.D.; Slater, L.; Stewart, J.C.; Tomich, C.E.; Vickers, R.A.; Wood, N.K.; Young, S.K., 1997:
Oral mucosal melanomas: the WESTOP Banff workshop proceedings. Western Society of Teachers of Oral Pathology

Richards, A.; Costelloe, M.A.; Eveson, J.W.; Scully, C.; Irvine, G.H.; Rooney, N., 2000:
Oral mucosal non-Hodgkin's lymphoma--a dangerous mimic

Wittkowsky, A.K.; Reddy, R.; Bardy, G.H., 1995:
Oral mucosal ulceration from disopyramide

Jacobs, R.; Wu, C-H.; Goossens, K.; Van Loven, K.; Van Hees, J.; Van Steenberghe, D., 2002:
Oral mucosal versus cutaneous sensory testing: a review of the literature

Köstler, W.J.; Hejna, M.; Wenzel, C.; Zielinski, C.C., 2001 :
Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment

Raber-Durlacher, J.E.; Weijl, N.I.; Abu Saris, M.; de Koning, B.; Zwinderman, A.H.; Osanto, S., 2000:
Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases

Johansson, G.; Andersson, G.; Attstöm, R.; Edwardsson, S., 2002:
Oral mucous membrane flora in patients using saliva substitutes

Heher, K.L.; Katowitz, J.A., 1997:
Oral mucous membrane grafts for corneal protection to permit prosthetic shell wear

Erol, B.; Unlü, G.; Balci, K.; Tanrikulu, R., 2001:
Oral myiasis caused by hypoderma bovis larvae in a child: a case report

Henry, J., 1996:
Oral myiasis: a case study

al-Ismaily, M.; Scully, C., 1995:
Oral myiasis: report of two cases

Jones, A.C.; Freedman, P.D.; Kerpel, S.M., 1994:
Oral myofibromas: a report of 13 cases and review of the literature

Corson, M.A.; Reed, M.; Soames, J.V.; Seymour, R.A., 2002:
Oral myofibromatosis: an unusual cause of gingival overgrowth

Garretto, A.L., 1993:
Oral myofunctional therapy in Argentina

Meissner, W.; Schmidt, U.; Hartmann, M.; Kath, R.; Reinhart, K., 1999:
Oral naloxone reverses opioid-associated constipation

Anonymous, 1998:
Oral naratriptan approved for migraine attacks

Shay, K., 1990:
Oral neglect in the institutionalized elderly. Part 1: The role of the institution

Shay, K., 1990:
Oral neglect in the institutionalized elderly. Part 2: The role of the dentist and the standard of care

Fadda, G., 2001:
Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol

Westman, E.C.; Tomlin, K.F.; Perkins, C.E.; Rose, J.E., 2001:
Oral nicotine solution for smoking cessation: a pilot tolerability study

Brisinda, G.; Maria, G., 2000:
Oral nifedipine reduces resting anal pressure and heals chronic anal fissure

Hackett, R.P.; Ducharme, N.G.; Gleed, R.D.; Erb, H.N.; Mitchell, L.M.; Soderholm, L.V., 2000:
Oral nitroglycerin paste did not lower pulmonary capillary pressure during treadmill exercise

Alkan, A.; Günhan, O.; Celenk, P., 2001:
Oral nodular fasciitis: a case report

Carbonell, E.; Sabater, V.; Milian, M.-A.; Jimenez, Y.; Lloria, E.; Cardona, F., 1997:
Oral nodular fascitis

Gerrior, J.L.; Bell, S.J.; Wanke, C.A., 1998:
Oral nutrition for the patient with HIV infection

Malaty-Vaccari, J., 2001:
Oral nutrition supplements for home use

Eisenbart, E.; Oster, P.; Schuler, M.; Schlierf, G., 1999:
Oral nutrition therapy in malnutrition

Markowitz, J.S.; McRae, A.L.; Sonne, S.C., 2000:
Oral nutritional supplementation for the alcoholic patient: a brief overview

Venegas, E.; Soto, A.; Cózar, M.V.; Pereira, J.L.; Romero, H.; García-Luna, P.P., 2001:
Oral nutritional supplements. Are they useful?

Krensavage, T.J., 1996:
Oral obturator a useful adjunct for fiberoptic tracheal intubation

Post, M.S.; Hendriks, D.F.; Van Der Mooren, M.J.; Van Baal, W.M.; Leurs, J.R.; Emeis, J.J.; Kenemans, P.; Stehouwer, C.D.A., 2002:
Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo- controlled, 12-week study in early postmenopausal women

MacLennan, A.; Lester, S.; Moore, V., 2001:
Oral oestrogen replacement therapy versus placebo for hot flushes

Botto, H.; Butreau-Lemaire, M.; Levy, S.; Delval, C., 1993:
Oral ofloxacin versus intramuscular ceftriaxone in antibiotic prophylaxis in transurethral prostate resection

Gomis, M.; Barberán, J.; Sánchez, B.; Khorrami, S.; Borja, J.; García-Barbal, J., 2000:
Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis

Remesar, X.; Guijarro, P.; Torregrosa, C.; Grasa, M.M.; López, J.; Fernández-López, J.A.; Alemany, M., 2000:
Oral oleoyl-estrone induces the rapid loss of body fat in Zucker lean rats fed a hyperlipidic diet

Cooke, C.E.; Mehra, I.V., 1994:
Oral ondansetron for preventing nausea and vomiting

Buser, K.S.; Joss, R.A.; Piquet, D.; Aapro, M.S.; Cavalli, F.; Haefliger, J.M.; Jungi, W.F.; Bauer, J.; Obrist, R.; Brunner, K.W., 1993:
Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study

Hesketh, P.J., 1994:
Oral ondansetron: a useful addition to the supportive care armamentarium?

Nowak, A.J.; Casamassimo, P.S., 1994:
Oral opening and other selected facial dimensions of children 6 weeks to 36 months of age

Dertwinkel, R.; Wiebalck, A.; Zenz, M.; Strumpf, M., 1996:
Oral opioids for long-term treatment of chronic non-cancer pain

Stein, C., 1996:
Oral opioids in chronic non-cancer pain. Prospective controlled studies needed!

Reed, K.; Newton, W., 2000:
Oral or IV antibiotics for the treatment of febrile children with UTIs?

Barkhof, F.; Polman, C., 1997:
Oral or intravenous methylprednisolone for acute relapses of MS?

Smith, M., 1999:
Oral or intravenous steroids in acute severe asthma

Elia, M., 1998:
Oral or parenteral therapy for B12 deficiency

Nyholm, E.S., 1999:
Oral or parenteral therapy for vitamin B12 deficiency

Moody, G.A.; Eaden, J.A.; Helyes, Z.; Mayberry, J.F., 1997:
Oral or rectal administration of drugs in IBD?

Hayden, F.G.; Jennings, L.; Robson, R.; Schiff, G.; Jackson, H.; Rana, B.; McClelland, G.; Ipe, D.; Roberts, N.; Ward, P., 2000:
Oral oseltamivir in human experimental influenza B infection

Harel-Raviv, M.; Gorsky, M.; Lust, I.; Raviv, E., 1996:
Oral osteomyelitis: pre-AIDS manifestation or strange coincidence?

Sayler, D., 2002:
Oral oversights

Moazzez, R.; Smith, B.G.; Bartlett, D.W., 2000:
Oral pH and drinking habit during ingestion of a carbonated drink in a group of adolescents with dental erosion

Gross, V.; Andus, T.; Caesar, I.; Bischoff, S.C.; Lochs, H.; Tromm, A.; Schulz, H.J.; Bär, U.; Weber, A.; Gierend, M.; Ewe, K.; Schölmerich, J., 1996:
Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group

Britten, C.D.; Baker, S.D.; Denis, L.J.; Johnson, T.; Drengler, R.; Siu, L.L.; Duchin, K.; Kuhn, J.; Rowinsky, E.K., 2000:
Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel

Caldemeyer, C.; Dowell, A.R., 1994:
Oral paging in a community hospital: is it used effectively?

Carrasco, T.; Malgosa, A., 1990:
Oral paleopathology and diet: interpretation of dental pathology in 112 individuals in a Talaiotic cemetery on Mallorca (6th to 2nd centuries B.C.E.)

Mohan, V.; Poongothai, S.; Pitchumoni, C.S., 1998:
Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis

Désir, B.; Poitras, P., 2002:
Oral pantoprazole for acid suppression in the treatment of patients with Zollinger-Ellison syndrome

Bicalho, R.N.; Santo, M.F.; de Aguiar, M.C.; Santos, V.R., 2001:
Oral paracoccidioidomycosis: a retrospective study of 62 Brazilian patients

Minguez, J.; Penarrocha, M.; Bonet, J.; Vera, F., 1996:
Oral paramandibular fibromatosis. Report of two cases

Chen; Langer, 2000:
Oral particulate delivery: status and future trends

Sharquie, K.E.; Al-Araji, A.; Hatem, A., 2002:
Oral pathergy test in Behçet's disease

Meyer, D.H.; Fives-Taylor, P.M., 1999:
Oral pathogens: from dental plaque to cardiac disease

Kramer, I.R., 1994:
Oral pathology 25 years on: British Society for Oral Pathology Silver Jubilee Lecture

Brannon, R.B.; Carr, R.F.; Weir, J.C., 1997:
Oral pathology biopsy service at the Louisiana State University School of Dentistry: status report 1995

Vanderbeck, L.A.; Nieves, G.; Goodwin, A., 1998:
Oral pathology case study

Cocchi, F.; Armanino, R.; Del Bono, P.; Gandolfo, A.M.; Mangiante, S.; Pannacciulli, F.; Turchetti, S., 1994:
Oral pathology in autologous bone marrow transplantation (ABMT). Its prevention and local treatment

van Lunsen, D.M.; Baart, J.A.; van Amerongen, W.E.; van der Waal, I., 1997:
Oral pathology in children. Part I. Diseases of the oral mucosa

van Lunsen, D.M.; Baart, J.A.; van Amerongen, W.E.; van der Waal, I., 1997:
Oral pathology in children. Part II. Abnormalities of the teeth

van Lunsen, D.M.; Baart, J.A.; van Amerongen, W.E.; van der Waal, I., 1997:
Oral pathology in children. Part III. Abnormalities of the jaw bones

Reichart, P.A., 1996:
Oral pathology of acquired immunodeficiency syndrome and oro-facial Kaposi's sarcoma

Doulabi, H.; Rastin, M.; Shabahangh, H.; Maddah, G.; Abdollahi, A.; Nosratabadi, R.; Esmaeili, S-Alireza.; Mahmoudi, M., 2018:
Analysis of Th22, Th17 and CD4+cells co-producing IL-17/IL-22 at different stages of human colon cancer

Durham, S.R.; Donaldson, K.; Grady, M.Sean.; Benzil, D.L., 2018:
Analysis of the 1990-2007 neurosurgery residency match: does applicant gender affect neurosurgery match outcome?

Kuchler, K.; Prifling, B.; Schmidt, D.; Markötter, H.; Manke, I.; Bernthaler, T.; Knoblauch, V.; Schmidt, V., 2018:
Analysis of the 3D microstructure of experimental cathode films for lithium-ion batteries under increasing compaction

Sentandreu, R.; Caminero, A.; Rentería, I.; León-Ramirez, C.; González-de-la-Vara, L.; Valentin-Gomez, E.; Ruiz-Herrera, Jé., 2018:
Analysis of the 3H8 antigen of Candida albicans reveals new aspects of the organization of fungal cell wall proteins

Kouprina, N.; Liskovykh, M.; Lee, N.C.O.; Noskov, V.N.; Waterfall, J.J.; Walker, R.L.; Meltzer, P.S.; Topol, E.J.; Larionov, V., 2018:
Analysis of the 9p21.3 sequence associated with coronary artery disease reveals a tendency for duplication in a CAD patient

de Hoyo, Més.; Sañudo, B.; Suárez-Arrones, L.; Carrasco, L.; Joel, T.; Domínguez-Cobo, S.; Núñez, F.J., 2017:
Analysis of the acceleration profile according to initial speed and positional role in elite professional male soccer players

Pires, P.Fernandes.; de Castro, E.Moreira.; Pelai, E.Bizetti.; de Arruda, A.Beatriz.Chiconelo.; Rodrigues-Bigaton, D., 2018:
Analysis of the accuracy and reliability of the Short-Form Fonseca Anamnestic Index in the diagnosis of myogenous temporomandibular disorder in women

Lima, J.Ataíde.Silva.; Rezende, H.Hallison.Alves.; Rocha, T.Mariana.Dias.Damas.; Castro, A.Maria.de., 2018:
Analysis of the accuracy of different laboratory methods for the diagnosis of intestinal parasites from stray and domiciled cats (Felis catus domesticus) in Goiânia, Goiás, Brazil

Kim, M-Hyeon.; Park, D-Hun.; Bae, M-Suk.; Song, S-Hui.; Seo, H-Ju.; Han, D-Gyun.; Oh, D-Sil.; Jung, S-Tae.; Cho, Y-Chang.; Park, K-Mok.; Bae, C-Sik.; Yoon, I-Soo.; Cho, S-Sik., 2018:
Analysis of the Active Constituents and Evaluation of the Biological Effects of Quercus acuta Thunb. (Fagaceae) Extracts

Zhai, X.; Hong, R.; Fan, Y.; Yuan, P.; Wang, J.; Sang, D.; Chen, J.; Zhao, C.; Ou, K.; Ma, F.; Xu, B., 2018:
Analysis of the activity and safety of weekly low-dose bevacizumab-based regimens in heavily pretreated patients with metastatic breast cancer

Monte-Secades, R.; Montero-Ruiz, E.; Feyjoo-Casero, J.; González-Anglada, M.; Freire-Romero, M.; Gil-Díaz, A.; Granados-Maturano, A.; Rubal-Bran, D.; Rabuñal-Rey, R.; Nevado Lopez-Alegria, L., 2018 :
Analysis of the activity of interconsultations conducted by the departments of internal medicine. REINA-SEMI study: Registry of Interconsultations and Shared Care of the Spanish Society of Internal Medicine

González-Costa, J.J.; Reigosa-Roger, M.J.; Matías, Jé.M.; Fernández-Covelo, E., 2018:
Analysis of the adsorption and retention models for Cd, Cr, Cu, Ni, Pb, and Zn through neural networks: selection of variables and competitive model

Miller, J.R.; Koren, S.; Dilley, K.A.; Puri, V.; Brown, D.M.; Harkins, D.M.; Thibaud-Nissen, Fçoise.; Rosen, B.; Chen, X-Guang.; Tu, Z.; Sharakhov, I.V.; Sharakhova, M.V.; Sebra, R.; Stockwell, T.B.; Bergman, N.H.; Sutton, G.G.; Phillippy, A.M.; Piermarini, P.M.; Shabman, R.S., 2018:
Analysis of the Aedes albopictus C6/36 genome provides insight into cell line utility for viral propagation

Fan, S.; Wang, Y.; Wang, X.; Huang, L.; Zhang, Y.; Liu, X.; Zhu, W., 2018:
Analysis of the affinity of influenza A virus protein epitopes for swine MHC I by a modified in vitro refolding method indicated cross-reactivity between swine and human MHC I specificities

Gasparini, B.; Valadão, M.; Miranda-Filho, A.; Silva, C.Marcelo.Furtado.Passos.da., 2018:
Analysis of the age-period-cohort effect on mortality from colorectal cancer in Rio de Janeiro State, Brazil, from 1980 to 2014

Liu, G-Yu.; Mei, X-Jiao.; Hu, M-Jun.; Yang, Y.; Liu, M.; Li, M-Si.; Zhang, M-Li.; Cao, M-Jie.; Liu, G-Ming., 2018:
Analysis of the allergenic epitopes of tropomyosin from mud crab using phage display and site-directed mutagenesis

Nandi, M.Kumar.; Maitra Bhattacharyya, S., 2018:
Analysis of the anomalous mean-field like properties of Gaussian core model in terms of entropy

Rump, A.; Stricklin, D.; Lamkowski, A.; Eder, S.; Abend, M.; Port, M., 2018:
Analysis of the antidote requirements and outcomes of different radionuclide decorporation strategies for a scenario of a "dirty bomb" attack

Garde, E.; Ramírez, L.; Corvo, L.; Solana, Jé.C.; Martín, M.Elena.; González, Víctor.M.; Gómez-Nieto, C.; Barral, A.; Barral-Netto, M.; Requena, Jé.M.; Iborra, S.; Soto, M., 2018:
Analysis of the Antigenic and Prophylactic Properties of the Leishmania Translation Initiation Factors eIF2 and eIF2B in Natural and Experimental Leishmaniasis

Souza, B.Martines.de.; Fernandes Neto, C.; Salomão, P.Maria.Aranda.; Vasconcelos, L.Reginna.Silva.Munhoz.de.; Andrade, F.Bombarda.de.; Magalhães, A.Carolina., 2018:
Analysis of the antimicrobial and anti-caries effects of TiF4 varnish under microcosm biofilm formed on enamel

Anonymous, 2018:
Analysis of the Article "Cas Rares," in the Dict. des Sciences Medicales

Cha, J.Doyun.; Lourenço, D.Budib.; Korkes, F., 2018:
Analysis of the association between bladder carcinoma and arsenic concentration in soil and water in southeast Brazil

Suárez-Esquivel, M.; Alfaro-Alarcón, A.; Guzmán-Verri, C.; Barquero-Calvo, Eías., 2017:
Analysis of the association between density of Helicobacter spp and gastric lesions in dogs

McGuinness, M.B.; Simpson, J.A.; Finger, R.P., 2017:
Analysis of the Association Between Physical Activity and Age-Related Macular Degeneration

Huo, X.; Zhang, L.; Li, T., 2018:
Analysis of the association of the expression of KiSS-1 in colorectal cancer tissues with the pathology and prognosis

Watanabe, T.; Suzuki, M., 2018:
Analysis of the audiogram shape in patients with idiopathic sudden sensorineural hearing loss using a cluster analysis

Arbeiter, M.; Petermann, S.; Hoppe, U.; Bohr, C.; Doellinger, M.; Ziethe, A., 2017:
Analysis of the Auditory Feedback and Phonation in Normal Voices

Zhong, H-Gang.; Liu, W-Hua.; Dong, F-Hui., 2018:
Analysis of the axial stretching force of the small splint fixation system

Kisková, J.; Stramová, Z.; Javorský, P.; Sedláková-Kaduková, J.; Pristaš, P., 2018:
Analysis of the bacterial community from high alkaline (pH > 13) drainage water at a brown mud disposal site near Žiar nad Hronom (Banská Bystrica region, Slovakia) using 454 pyrosequencing

Lee, J-Jae.; Kim, T-Yoon.; Choi, S.Ho.; Kim, B-Soo., 2017:
Analysis of the bacterial microbiome in the small octopus, Octopus variabilis, from South Korea to detect the potential risk of foodborne illness and to improve product management

Chang, H.; Zhou, B.; Cui, X.; Su, Y.; Ma, X., 2018:
Analysis of the bacteria spectrum and clinical treatment of topical skin infection during soft tissue expander implantation

Meier, E.; Perrier, M., 1994:
Oral pathology. A report on the Pindborg Course in Oral Pathology of 6 to 17 June 1994 in Copenhagen

Houston, G., 2001:
Oral pathology. Case of the quarter

Houston, G.D., 2001:
Oral pathology. Case of the quarter. Adenoid cystic carcinoma

Houston, G., 1999:
Oral pathology. Fall 1998 case of the month. Necrotizing sialometaplasia

Houston, G.D., 1999:
Oral pathology. May 1998 case of the month. Granular cell tumor

Prendiville, J.S.; Israel, D.M.; Wood, W.S.; Dimmick, J.E., 1994 :
Oral pemphigus vulgaris associated with inflammatory bowel disease and herpetic gingivostomatitis in an 11-year-old girl

Häusermann, P.; Gutersohn, T.; Beltraminelli, H.; Schiller, P.; Büchner, S.A.; Rufli, T., 2002:
Oral pemphigus vulgaris. Successful treatment with minocycline and nicotinamide

Kantipong, P.; Walsh, D.S., 2001:
Oral penicilliosis in a patient with human immunodeficiency virus in northern Thailand

Jull, A.B.; Waters, J.; Arroll, B., 2002:
Oral pentoxifylline for treatment of venous leg ulcers

Pollice, P.F.; Rosier, R.N.; Looney, R.J.; Puzas, J.E.; Schwarz, E.M.; O'Keefe, R.J., 2001:
Oral pentoxifylline inhibits release of tumor necrosis factor-alpha from human peripheral blood monocytes : a potential treatment for aseptic loosening of total joint components

Lee, H.J.; Amidon, G.L., 1995:
Oral peptide delivery: improving the systemic availability of small peptides and enkephalin analogs

Leung, K.C.M.; Pow, E.H.N.; McMillan, A.S.; Wong, M.C.M.; Li, L.S.W.; Ho, S-L., 2002:
Oral perception and oral motor ability in edentulous patients with stroke and Parkinson's disease

Dahan, J.S.; Lelong, O.; Celant, S.; Leysen, V., 2000:
Oral perception in tongue thrust and other oral habits

Lewis, C.A., 1993:
Oral pessimism and depressive symptoms

Niessen, L., 1994:
Oral pharmaceuticals and adult dental patients

Flores-Murrieta, F.J.; Aguilar-Cota, M.E.; Granados-Soto, V.; Medina-Santillán, R.; Reyes-García, G.; Herrera, J.E., 2002:
Oral pharmacokinetics of cefaclor in Mexican subjects

Riddle, M.C., 1999:
Oral pharmacologic management of type 2 diabetes

Pranzatelli, M.R., 1996:
Oral pharmacotherapy for the movement disorders of cerebral palsy

Rosen, R.C.; Phillips, N.A.; Gendrano, N.C.; Ferguson, D.M., 1999:
Oral phentolamine and female sexual arousal disorder: a pilot study

McCleane, G.J., 1996:
Oral phentolamine mesylate in the treatment of complex regional pain syndrome

Goldstein, I., 2000:
Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction

Ritz, E.; Hergesell, O., 1996:
Oral phosphate binders without aluminium and calcium - a pipe-dream?

Larner, A.J., 1994:
Oral phosphate supplements reverse skeletal muscle abnormalities in a case of chronic fatigue with idiopathic renal hypophosphataemia

Land, J.M.; Kemp, G.J.; Taylor, D.J.; Standing, S.J.; Radda, G.K.; Rajagopalan, B., 1993:
Oral phosphate supplements reverse skeletal muscle abnormalities in a case of chronic fatigue with idiopathic renal hypophosphatemia

Dibart, S.; D.F.o, P.; Surabian, G.; Hart, A.; Capri, D.; Su, M-Fan., 2002:
Oral piercing and gingival recession: review of the literature and a case report

Lenane, P.; Powell, F.C., 2001:
Oral pigmentation

Mowad, C.M.; Shrager, J.; Elenitsas, R., 1997:
Oral pigmentation representing Laugier-Hunziker syndrome

Gaeta, G.M.; Satriano, R.A.; Baroni, A., 2002:
Oral pigmented lesions

Wynn, R.L., 1996:
Oral pilocarpine (Salagen)--a recently approved salivary stimulant

Rhodus, N.L., 1997:
Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome

Papas, A.S.; Fernandez, M.M.; Castano, R.A.; Gallagher, S.C.; Trivedi, M.; Shrotriya, R.C., 1998:
Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjögrens syndrome

Nelson, J.D.; Friedlaender, M.; Yeatts, R.P.; Yee, R.; McDermott, M.; Orlin, S.; Gallagher, S.C.; Shrotriya, R.C., 1998:
Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. The MGI PHARMA Sjögren's Syndrome Study Group

Anonymous, 1994:
Oral pilocarpine for xerostomia

Kumar, S.; Tyler, A.B.; Phillips, S.; Burnet, N.G., 1997:
Oral pilocarpine improves radiotherapy-induced dry eyes

Anonymous, 2002:
Oral pilocarpine: new preparation. Xerostomia after radiation therapy: moderately effective but costly

Gurbel, P.A.; Serebruany, V.L., 2000:
Oral platelet IIb/IIIa inhibitors: from attractive theory to clinical failures

Newby, L.K.; McGuire, D.K., 2000:
Oral platelet glycoprotein IIb/IIIa inhibition

Vorchheimer, D.A.; Fuster, V., 1998:
Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety

van de Vaart, P.J.; Klaren, H.M.; Hofland, I.; Begg, A.C., 1998:
Oral platinum analogue JM216, a radiosensitizer in oxic murine cells

Larsen, L.C.; Cummings, D.M., 1998:
Oral poisonings: guidelines for initial evaluation and treatment

Kops, S.P., 2001:
Oral polio vaccine and human cancer: a reassessment of SV40 as a contaminant based upon legal documents

Anonymous, 2001:
Oral polio vaccine/AIDS theory refuted!

Wiersbitzky, S., 1993:
Oral poliomyelitis vaccination: why should transmission of vaccine viruses to unvaccinated infants be avoided if possible?

Hanna, J., 1996:
Oral poliomyelitis vaccines

Anonymous, 2001:
Oral poliovirus vaccine (OPV) and intussusception

Tekin, A.; Tekgul, S.; Atsu, N.; Bakkaloglu, M.; Kendi, S., 2002:
Oral potassium citrate treatment for idiopathic hypocitruria in children with calcium urolithiasis

James, F.M., 1999:
Oral practice examinations: are they worth it?

Sciubba, J.J., 2002:
Oral precancer and cancer: etiology, clinical presentation, diagnosis, and management

Pietinalho, A.; Tukiainen, P.; Haahtela, T.; Persson, T.; Selroos, O., 1999:
Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group

Maeda, A.; Yamanouchi, H.; Lee, J.B.; Katayama, I., 2000:
Oral prednisolone improved acetylcholine-induced sweating in Sjögren's syndrome-related anhidrosis

Azuara-Blanco, A.; Spaeth, G.L.; Augsburger, J.J., 1999:
Oral prednisone in guarded filtration procedures supplemented with antimetabolites

Silverman, S.; Sugerman, P.B., 2001:
Oral premalignancies and squamous cell carcinoma

Wilkinson, J.; Gill, A.; Farrell, M., 1999:
Oral premedication for children undergoing cardiac catheterisation

Gianoutsos, M.P.; Hunter-Smith, D.; Smith, J.G.; Hogan, D.; McEwan, L., 1994:
Oral premedication for local anesthesia in plastic surgery: prospective, randomized, blind comparison of lorazepam and temazepam

Beer, G.M.; Spicher, I.; Seifert, B.; Emanuel, B.; Kompatscher, P.; Meyer, V.E., 2001 :
Oral premedication for operations on the face under local anesthesia: a placebo-controlled double-blind trial

Alderson, P.J.; Lerman, J., 1994:
Oral premedication for paediatric ambulatory anaesthesia: a comparison of midazolam and ketamine

Ostreĭkov, I.F.; Pivovarov, S.A.; Milenin, V.V.; Vasil'ev, I.I., 2002:
Oral premedication in ambulatory surgical otorhinolaryngology in children

Fanini, D.; Poglio, M.; Marci, M.C.; Iovinelli, G.; Antenucci, F., 1998:
Oral premedication with clonidine as an alternative in dental practice. The effects on the pain threshold, blood pressure and salivary flow

García-Guiral, M.; García del Valle, S.; Carrera, A.; Martínez, M.V.; Arribas, M.J.; Escarpa, A., 1994:
Oral premedication with clonidine in patients undergoing coronary revascularization surgery

Kretz, F.J.; Gonzales, I.; Peidersky, P., 1993:
Oral premedication with clorazepate dipotassium. Comparison with oral premedication with flunitrazepam and intramuscular premedication with promethazine, pethidine and atropine in adults

Hyndman, J., 1993:
Oral premedication with methadone, promethazine and diclofenac

Riva, J.; Lejbusiewicz, G.; Papa, M.; Lauber, C.; Kohn, W.; D.F.nte, M.; Burgstaller, H.; Comellas, C.; Ayala, W., 1997:
Oral premedication with midazolam in paediatric anaesthesia. Effects on sedation and gastric contents

Fincher, R.K.; Wong, R.K.; Osgard, E.M., 2001:
Oral preparations for flexible sigmoidoscopy

Uppal, S.; De, P.R., 2000:
Oral presentation of an oesophageal mucosal tear

Scully, C.; Eveson, J.W.; Witherow, H.; Young, A.H.; Tan, R.S.; Gilby, E.D., 1993:
Oral presentation of lymphoma: case report of T-cell lymphoma masquerading as oral Crohn's disease, and review of the literature

Omovie, E.E.; Absi, E.G.; Hill, C.M.; Ezsias, A.; Potts, A.J., 1995:
Oral presentation of metastatic calcinosis cutis

Oda, D.; Persson, G.R.; Haigh, W.G.; Sabath, D.E.; Penn, I.; Aziz, S., 1996:
Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation

Rogers, B., 1999:
Oral presentation of research

Rodríguez de Castro, F., 1999:
Oral presentation of scientific research

Anonymous, 1999:
Oral presentations

Anonymous, 2000:
Oral presentations

Perraudin, J.P.; Pourtois, M., 1997:
Oral prevention and care in cancer patients. Lack of saliva can be dangerous

Hassell, T.M.; Burtner, A.P.; McNeal, D.; Smith, R.G., 1994:
Oral problems and genetic aspects of individuals with epilepsy

Krishnasamy, M., 1995:
Oral problems in advanced cancer

Peterson, D.E., 2000:
Oral problems in supportive care: no longer an orphan topic?

Thompson, C.A., 2001:
Oral prodrug enters cephalosporin market

Anonymous, 2001:
Oral prodrug of ganciclovir approved for CMV retinitis

Heinemann, L.A.; Assmann, A.; DoMinh, T.; Garbe, E., 1999:
Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women

Femiano, F.; Gombos, F.; Scully, C., 2001:
Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL

Hughes, C.; Sunderji, R.; Gin, K., 1997:
Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review

Chowdhury, M.M.; Marks, R., 2002:
Oral propylthiouracil for the treatment of resistant plaque psoriasis

Hyman, A.; Yim, C.; Krajden, M.; Read, S.; Basinski, A.S.; Wanless, I.; Levy, G.; Heathcote, J., 1999:
Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C

French, L., 2001:
Oral prostaglandin E2 for induction of labour

Helton, W.S.; Garcia, R., 1993:
Oral prostaglandin E2 prevents gut atrophy during intravenous feeding but not bacterial translocation

Jokstad, Aørn., 2002:
Oral prosthetics from a Nordic perspective

Douglas, B.L., 1995:
Oral protection for equestrians

Wang, W., 1996:
Oral protein drug delivery

Stern, R.S.; Liebman, E.J.; Väkevä, L., 1998:
Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study

Morison, W.L.; Nesbitt, J.A., 1993:
Oral psoralen photochemotherapy (PUVA) for pruritus associated with polycythemia vera and myelofibrosis

Abdel-Naser, M.B.; Hann, S.K.; Bystryn, J.C., 1998:
Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation

Hofer, A.; Soyer, H.P., 1999:
Oral psoralen-UV-A for systemic scleroderma

Yamamoto, T.; Nishioka, K., 2002:
Oral psoriasis in a patient with hepatitis C virus infection

Pyle, G.W.; Vitt, M.; Nieusma, G., 1994:
Oral psoriasis: report of case

Rozell, B.; Grevér, A.C.; Marcusson, J.A., 1997:
Oral psoriasis: report on a case without epidermal involvement

Matuszkiewicz-Rowińska, J.; Niemczyk, S.; Bogdańska-Straszyńska, B.; Ostrowski, K., 1993:
Oral pulsatile therapy with active vitamin D3 metabolites--an efficient method of parathyroid hormone synthesis suppression in uremic patients with severe hyperparathyroidism. A pilot study

Newman, L.N.; Ferrara, K.A.; Tessman, M.J.; Hart, J.J.; Cacho, C.P., 1997:
Oral pulsed calcitriol protocol reduces the prevalence of hyperparathyroidism in a PD unit

Zain, R.B.; Khoo, S.P.; Yeo, J.F., 1995:
Oral pyogenic granuloma (excluding pregnancy tumour)--a clinical analysis of 304 cases

Cheng, T.O., 2002:
Oral quinidine therapy for chronic atrial fibrillation

Linhart, S.B.; King, R.; Zamir, S.; Naveh, U.; Davidson, M.; Perl, S., 1998:
Oral rabies vaccination of red foxes and golden jackals in Israel: preliminary bait evaluation

Wagner, B.; Nagata, M., 1994:
Oral ranitidine as stress ulcer prophylaxis: serum concentrations and cost comparisons

Mancano, M.A.; Boullata, J.I., 1994:
Oral ranitidine for gastric stress ulcer prophylaxis intensive care unit patients

Sorribes, M.M.; Jensen, R.K.; Charabi, S.; Balle, V.H., 1999:
Oral ranula. A follow-up study

Weekes, B., 2000:
Oral reading in Chinese: evidence from dementia of the Alzheimer's type

Noble, K.; Glosser, G.; Grossman, M., 2000:
Oral reading in dementia

Vazeille-Falcoz, M.; Failloux, A.B.; Mousson, L.; Elissa, N.; Rodhain, F., 2000:
Oral receptivity of Aedes aegypti formosus from Franceville (Gabon, central Africa) for type 2 dengue virus

Ikeda, K.; Yokoyama, M.; Okada, K.; Tomita, K.; Nagayama, I., 1998:
Oral reconstruction using the peroneal flap

Zain, R.B., 2000:
Oral recurrent aphthous ulcers/stomatitis: prevalence in Malaysia and an epidemiological update

Bushehri, N.; Jarrell, S.T.; Lieberman, S.; Mirdamadi-Zonozi, N.; Birkmayer, G.; Preuss, H.G., 1999:
Oral reduced B-nicotinamide adenine dinucleotide (NADH) affects blood pressure, lipid peroxidation, and lipid profile in hypertensive rats (SHR)

Joshi, N.; Parkash, H., 1998:
Oral rehabilitation in dentinogenesis imperfecta with overdentures: case report

Matsumoto, M., 1993:
Oral rehabilitation in occlusal treatment

Bonilla, E.D.; Luna, O., 2001:
Oral rehabilitation of a bulimic patient: a case report

Siegel, S.C.; O'Connell, A., 2000:
Oral rehabilitation of a child with primary failure of tooth eruption

Itthagarun, A.; King, N.M., 2001:
Oral rehabilitation of a hypohidrotic ectodermal dysplasia patient: a 6-year follow-up

Thompson, G.A.; Schwartz, J.M., 1998:
Oral rehabilitation of a patient with amelogenesis imperfecta

Betz, T.; Purps, S.; Pistner, H.; Bill, J.; Reuther, J., 1999:
Oral rehabilitation of tumor patients with endosseous implants. Implant success with special reference to peri-implant tissue

Peñarrocha, M.; Sanchis, J.M.; Rambla, J.; Guarinos, J., 2001:
Oral rehabilitation using osseointegrated implants in a patient with idiopathic torsion dystonia

Chan, M.F.; Hayter, J.P.; Cawood, J.I.; Howell, R.A., 1998:
Oral rehabilitation with implant-retained prostheses following ablative surgery and reconstruction with free flaps

Penarrocha, M.; Sanchis, J.-M.; Frutos, J.-R.; Estrela, F.; Pi, J., 2001:
Oral rehabilitation with implants in a child with hypohidrotic ectodermal dysplasia

Peñarrocha, M.; Sanchis, J.M.; Rambla, J.; Sánchez, M.A., 2001:
Oral rehabilitation with osseointegrated implants in a patient with oromandibular dystonia with blepharospasm (Brueghel's syndrome): a patient history

Moskowitz, M., 1998:
Oral rehabilitation: restoring the triad of health, function, beauty

Gebesh, V.V., 1994:
Oral rehydration and enterosorption in the combined treatment of patients with intestinal and other infections

Cash, R.; Hirschhorn, N.; Nalin, D., 1999:
Oral rehydration and hyponatraemia

Fontaine, O.; Beau, J.P.; Ndiaye, A.M., 1985:
Oral rehydration and nutritional rehabilitation of severely malnourished children

Akpede, G.O.; Omotara, B.A., 1997 :
Oral rehydration at home--with a little help from friends

Weizman, Z.; Weizman, A.; Alsheikh, A.; Herzog, L.; Tal, A.; Gorodischer, R., 2001:
Oral rehydration in acute gastroenteritis in infants and children--advantages of a standardized protocol

Quijano-Pitman, F., 1995:
Oral rehydration in diarrheas: a Mexican priority

Lentidoro, I.; Anastasio, E.; Pensabene, L.; Apollini, M.; Guandalini, S., 1996:
Oral rehydration in infants with acute diarrhea: using a new preparation of reduced osmolarity

Dolezel, Z.; Kopecna, L.; Bartosova, D., 2002:
Oral rehydration in the therapy of simple diarrhea in infants and toddlers

Rhoads, J.M., 1998:
Oral rehydration pudding?

Pelleboer, R.A.; Tolboom, J.J., 1993:
Oral rehydration solution based on nutrition: a promising method

Pironi, L.; Guidetti, C.; Incasa, E.; Poggioli, G.; Paganelli, F.; Merli, C.; Fumi, L.; Miglioli, M., 2001:
Oral rehydration solution containing rice maltodextrins in patients with total colectomy and high intestinal output

Duggan, C.; Lasche, J.; McCarty, M.; Mitchell, K.; Dershewitz, R.; Lerman, S.J.; Higham, M.; Radzevich, A.; Kleinman, R.E., 1999:
Oral rehydration solution for acute diarrhea prevents subsequent unscheduled follow-up visits

Desjeux, J.F.; Briend, A.; Butzner, J.D., 1998:
Oral rehydration solution in the year 2000: pathophysiology, efficacy and effectiveness

Vashishtha, V.M., 2001:
Oral rehydration solution. Doctors in India still seem not to be convinced

Duggan, C., 2001:
Oral rehydration solution. Doctors must increase use and acceptance of oral rehydration solution

Ho, T.F.; Yip, W.C., 2001:
Oral rehydration solution. Rice water is cheap and effective

Greenough, W.B., 1996:
Oral rehydration solutions

Barnes, G.L., 1996:
Oral rehydration solutions in gastroenteritis before and after admission to hospital

Hugger, J.; Harkless, G.; Rentschler, D., 1999:
Oral rehydration therapy for children with acute diarrhea

Santosham, M.; Keenan, E.M.; Tulloch, J.; Broun, D.; Glass, R., 1998:
Oral rehydration therapy for diarrhea: an example of reverse transfer of technology

Anonymous, 1997:
Oral rehydration therapy for pediatric gastroenteritis

Rhoads, M., 1996:
Oral rehydration therapy for viral enteritis

Rhoads, F.A., 1993:
Oral rehydration therapy for viral gastroenteritis

Hoekstra, J.H., 1993:
Oral rehydration therapy in Europe

Rossboth, D.W.; Hagymási, K.; Fehér, J., 1998:
Oral rehydration therapy in the management of diarrhea

Ogunbodede, E.O.; Sheiham, A., 1996:
Oral rehydration therapy--a dental perspective

Straughn, A.; English, B., 1996:
Oral rehydration therapy. A neglected treatment for pediatric diarrhea

Golergant, D.; Dumont-Driscoll, M.; Pollock, B.H.; Eitzman, D.; Neiberger, R.E., 1994:
Oral rehydration therapy. North Florida physicians' attitudes

Fontaine, O., 2000:
Oral rehydration therapy: a critical component in integrated management of childhood illness

Danis, D.M., 1993:
Oral rehydration therapy: a new document and standard of care

Dohi-Fujii, B.; Godoy-Olvera, L.M.; Durazo-Ortíz, J., 1993:
Oral rehydration therapy: an analysis of its results and impact on the hospitalization and mortality of children with diarrhea

Meyers, A., 1993:
Oral rehydration therapy: what are we waiting for?

Avery, M.E.; Snyder, J., 1987:
Oral rehydration therapy; an American perspective

Nethander, G., 1995:
Oral restoration with fixed partial dentures on transplanted abutment teeth

Gollnick, H.P., 1996:
Oral retinoids--efficacy and toxicity in psoriasis

Razafindrakoto, O.; Ravelomanana, N.; Randriamiharisoa, F.; Rasoarivao, V.; Ramialimanana, V.; Rakotoarimanana, D.R.; Razanamparany, M., 1993:
Oral rice-based rehydration solution (SRO), alternative of SRO of WHO in acute diarrhea in malnourished patients

Shirtliff, M.E.; Mader, J.T.; Calhoun, J., 1999:
Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits

Drancourt, M.; Stein, A.; Argenson, J.N.; Zannier, A.; Curvale, G.; Raoult, D., 1993:
Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants

Tfelt-Hansen, P.; Teall, J.; Rodriguez, F.; Giacovazzo, M.; Paz, J.; Malbecq, W.; Block, G.A.; Reines, S.A.; Visser, W.H., 2001:
Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group

Canonica, G.W.; Passalacqua, G.; Mariani, G.; Motta, C.; Bartolomei, M.; Mistrello, G.; Falagiani, P.; Bagnasco, M., 1997:
Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen

Speedy, D.B.; Thompson, J.M.D.; Rodgers, I.; Collins, M.; Sharwood, K.; Noakes, T.D., 2002:
Oral salt supplementation during ultradistance exercise

Gansky, S.A.; Ellison, J.A.; Kavanagh, C.; Hilton, J.F.; Walsh, M.M., 2002:
Oral screening and brief spit tobacco cessation counseling: a review and findings

Tickle, M.; Milsom, K., 1999:
Oral screening: time for a change of terminology and methodology

Touyz, L.Z., 1998:
Oral scurvy and periodontal disease

Li, T.J.; Kitano, M.; Mukai, H.; Yamashita, S., 1997:
Oral sebaceous carcinoma: report of a case

Dionne, R., 1998:
Oral sedation

Gatti, J.E., 2000:
Oral sedation allows for comfort and amnesia during office surgery

Tanguy, S.; Boucher, F.; Besse, S.; Toufektsian, M.C.; Ducros, V.; Favier, A.; de Leiris, J., 2000:
Oral selenium supplementation in rats does not protect isolated rings of aorta against exogenous hydrogen peroxide

Boucher, F.; Coudray, C.; Tirard, V.; Barandier, C.; Tresallet, N.; Favier, A.; de Leiris, J., 1995:
Oral selenium supplementation in rats reduces cardiac toxicity of adriamycin during ischemia and reperfusion

Karikoski, A.; Ilanne-Parikka, P.; Murtomaa, H., 2002:
Oral self-care among adults with diabetes in Finland

Karikoski, A.; Ilanne-Parikka, P.; Murtomaa, H., 2002:
Oral self-care and periodontal health indicators among adults with diabetes in Finland

Polychronopoulou, A.; Kawamura, M.; Athanasouli, T., 2002:
Oral self-care behavior among dental school students in Greece

Saito, T.; Koga, T., 2000:
Oral self-mutilation

Bonin, B.; Labarte, F.; Van Hove, A.; Picard, A.; Goga, D., 2002:
Oral self-mutilation and congenital analgesia: diagnosis and therapeutic problems. Apropos of a case

Rashid, N.; Yusuf, H., 1997:
Oral self-mutilation by a 17-month-old child with Lesch-Nyhan syndrome

Lee, J-Ho.; Berkowitz, R.J.; Choi, B-Jai., 2002:
Oral self-mutilation in the Lesch-Nyhan syndrome

Harrison, M.; Roberts, G.J.; Morgan, P.R.; Pinkerton, R., 1998:
Oral self-mutilation masquerading as malignancy

Smith, C.H.; Logemann, J.A.; Burghardt, W.R.; Carrell, T.D.; Zecker, S.G., 1997:
Oral sensory discrimination of fluid viscosity

Levenson, M.F., 1999:
Oral sequelae of chemotherapy: a complex problem that can be solved by prevention

Sadler, G.R.; Oberle-Edwards, L.; Farooqi, A.; Hryniuk, W.M., 2000:
Oral sequelae of chemotherapy: an important teaching opportunity for oncology health care providers and their patients

Lindley, C.; Blower, P., 2000:
Oral serotonin type 3-receptor antagonists for prevention of chemotherapy-induced emesis

Anonymous, 1996:
Oral sex

Remez, L., 2001:
Oral sex among adolescents: is it sex or is it abstinence?

Anonymous, 2001:
Oral sex and HIV: new study rekindles debate

Stanley, B., 1999:
Oral sex and the transmission of non-viral STIs

Edwards, S.; Carne, C., 1998:
Oral sex and transmission of non-viral STIs

Waalen, J., 1996:
Oral sex in spotlight for HIV transmission

Anonymous, 2000:
Oral sex more risky

Molina, C.N., 1995:
Oral sex without a condom--is it safe or not?

Molina, C.N., 2001:
Oral sex without a condom?

Wohlfeiler, D., 2001:
Oral sex: it's up to you

Boekeloo, B.O.; Howard, D.E., 2002:
Oral sexual experience among young adolescents receiving general health examinations

Cook, D.J.; Hollowood, T.A.; Linforth, R.S.T.; Taylor, A.J., 2002:
Oral shear stress predicts flavour perception in viscous solutions

Scott, D.A.; Coulter, W.A.; Lamey, P.J., 1998:
Oral shedding of herpes simplex virus type 1: a review

Kane, M.; Zacharczenko, N., 1993:
Oral side effects of drugs

Field, E.A.; Longman, L.P.; Fear, S.; Higham, S.; Rostron, J.; Willetts, R.M.; Ireland, R.S., 2001:
Oral signs and symptoms as predictors of salivary gland hypofunction in general dental practice

Zachariasen, R.D., 1997:
Oral signs and symptoms of bulimia nervosa

Gilbert, G.H.; Heft, M.W.; Duncan, R.P., 1993:
Oral signs, symptoms, and behaviors in older Floridians

Sairam, K.; Kulinskaya, E.; Hanbury, D.; Boustead, G.; McNicholas, T., 2002:
Oral sildenafil (Viagra) in male erectile dysfunction: use, efficacy and safety profile in an unselected cohort presenting to a British district general hospital

van der Linde, I., 1998:
Oral sildenafil (Viagra) on trial

Padma-Nathan, H., 2000:
Oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction: assessment of erections hard enough for sexual intercourse

Chan-Tack, K.M., 1998:
Oral sildenafil in erectile dysfunction

Goldstein, I.; Lue, T.F.; Padma-Nathan, H.; Rosen, R.C.; Steers, W.D.; Wicker, P.A., 2002:
Oral sildenafil in the treatment of erectile dysfunction. 1998

Furukawa, S.; Kouyama, H.; Kikumori, M.; Taniguchi, Y.; Nishimori, T.; Ishibashi, S.; Iwakura, K.; Sumi, N., 1997:
Oral single-dose and 13-week repeat-dose toxicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in rats

Polglase, A.L., 1993:
Oral sodium phosphate bowel preparation for colonoscopy

Warner, B.A.; DiPalma, J.A., 1994:
Oral sodium phosphate catharsis: "first do no harm"

Young, C.J.; Simpson, R.R.; King, D.W.; Lubowski, D.Z., 2000:
Oral sodium phosphate solution is a superior colonoscopy preparation to polyethylene glycol with bisacodyl

Clarkston, W.K.; Tsen, T.N.; Dies, D.F.; Schratz, C.L.; Vaswani, S.K.; Bjerregaard, P., 1996:
Oral sodium phosphate versus sulfate-free polyethylene glycol electrolyte lavage solution in outpatient preparation for colonoscopy: a prospective comparison

Mitchell, J.F.; Liadis, M., 1982:
Oral solid dosage forms that should not be crushed prior to administration

Mitchell, J.F.; Pawlicki, K.S., 1994:
Oral solid dosage forms that should not be crushed: 1994 revision

Ide, F.; Saito, I., 2002:
Oral solitary fibrous tumour

Djaldetti, R.; Inzelberg, R.; Giladi, N.; Korczyn, A.D.; Peretz-Aharon, Y.; Rabey, M.J.; Herishano, Y.; Honigman, S.; Badarny, S.; Melamed, E., 2002:
Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease

Meurman, J.H.; Pyrhönen, S.; Teerenhovi, L.; Lindqvist, C., 1998:
Oral sources of septicaemia in patients with malignancies

Gaetti-Jardim, E.; Zelante, F.; Avila-Campos, M.J., 1996:
Oral species of Fusobacterium from human and environmental samples

ter Steege, J.C.; Forget, P.P.; Buurman, W.A., 1999:
Oral spermine administration inhibits nitric oxide-mediated intestinal damage and levels of systemic inflammatory mediators in a mouse endotoxin model

Said-Al-Naief, N.; Zahurullah, F.R.; Sciubba, J.J., 2001:
Oral spindle cell lipoma

Hatsukami, D.K.; Severson, H.H., 2000:
Oral spit tobacco: addiction, prevention and treatment

Saeed, N.R.; Gold, J.A., 1994:
Oral squamous cell carcinoma

van der Waal, R.I.; Snow, G.B.; van der Waal, I., 1997:
Oral squamous cell carcinoma as a second primary malignancy in a patient with previously diagnosed osteosarcoma of the femur

Anil, S.; Beena, V.T.; Raji, M.A.; Remani, P.; Ankathil, R.; Vijayakumar, T., 1994:
Oral squamous cell carcinoma in a case of dyskeratosis congenita

Faragalla, F., 2002:
Oral squamous cell carcinoma in a pregnant mare

Berndt, A.; Hyckel, P.; Könneker, A.; Katenkamp, D.; Kosmehl, H., 1997:
Oral squamous cell carcinoma invasion is associated with a laminin-5 matrix re-organization but independent of basement membrane and hemidesmosome formation. clues from an in vitro invasion model

Llewelyn, J., 1994:
Oral squamous cell carcinoma. Mouthwashes may increase risk

Feaver, G.P., 1994:
Oral squamous cell carcinoma. Results of screening are encouraging

Gervásio, O.L.; Dutra, R.A.; Tartaglia, S.M.; Vasconcellos, W.A.; Barbosa, A.A.; Aguiar, M.C., 2001:
Oral squamous cell carcinoma: a retrospective study of 740 cases in a Brazilian population

Arotiba, J.T.; Obiechina, A.E.; Fasola, O.A.; Fawole, O.I.; Ajagbe, H.A., 2001:
Oral squamous cell carcinoma: a review of 246 Nigerian cases

Jordan, R.C.; Daley, T., 1997:
Oral squamous cell carcinoma: new insights

Scully, C., 2002:
Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission

Wolff, E.; Girod, S.; Liehr, T.; Vorderwülbecke, U.; Ries, J.; Steininger, H.; Gebhart, E., 1998:
Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation

Astakhova, N.M.; Korel', A.V.; Shchelkunova, E.I.; Orishchenko, K.E.; Nikolaev, S.V.; Zubairova, U.S.; Kirilova, I.A., 2018:
Analysis of the Basic Characteristics of Osteogenic and Chondrogenic Cell Lines Important for Tissue Engineering Implants

Lamy, M.; Mojon, P.; Kalykakis, G.; Legrand, R.; Butz-Jorgensen, E., 1999:
Oral status and nutrition in the institutionalized elderly

Sumi, Y., 2001:
Oral status and oral care of dependent elderly

Ohrn, K.E.; Wahlin, Y.B.; Sjödén, P.O., 2001:
Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications

Ohrn, R.; Angmar-Månsson, B., 2000:
Oral status of 35 subjects with eating disorders--a 1-year study

Komar, D.; Celebić, A.; Stipetić, J.; Lazić, B.; Baucić, I.; Lazić, D.; Bratolić, V.; Perisin, T., 2003:
Oral status, aesthetic materials and frequency of crowns and bridges in patients with fixed prosthetic appliances living in the Metković region

Nordenram, G.; Ljunggren, G., 2002:
Oral status, cognitive and functional capacity versus oral treatment need in nursing home residents: a comparison between assessments by dental and ward staff

Mantecchini, G.; Bassi, F.; Pera, P.; Preti, G., 1998:
Oral stereognosis in edentulous subjects rehabilitated with complete removable dentures

Pow, E.H.; Leung, K.C.; McMillan, A.S.; Wong, M.C.; Li, L.S.; Ho, S.L., 2001:
Oral stereognosis in stroke and Parkinson's disease: a comparison of partially dentate and edentulous individuals

Jacobs, R.; Bou Serhal, C.; van Steenberghe, D., 1998:
Oral stereognosis: a review of the literature

Smith, P.W.; McCord, J.Fraser., 2002:
Oral stereognostic ability in edentulous and dentate individuals

Anonymous, 1975:
Oral steroid contraceptive for men

Westbroek, J.; Saarelainen, S.; Laher, M.; O'Brien, J.; Barnacle, H.; Efthimiou, J., 1999:
Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma

Sinnathuray, T.A., 1988:
Oral steroidal contraception: scientific basis and recent development

Lasserson, T.; Holt, K.; Greenstone, M., 2001:
Oral steroids for bronchiectasis (stable and acute exacerbations)

Cheng, K.; Ashby, D.; Smyth, R., 2000:
Oral steroids for cystic fibrosis

Golder, J., 1999:
Oral steroids in the treatment of otitis externa

Kulkarni, M.L.; Kumar, C.S.; George, V.G.; Farooq, K., 1993:
Oral steroids in the treatment of periorbital hemangioma

Meghji, S.; Haque, M.F.; Harris, M., 1997:
Oral submucous fibrosis and copper

Que, G.Y.; Peng, J.Y., 2002:
Oral submucous fibrosis complicated with lichen planus disease

Yusuf, H.; Yong, S.L., 2002:
Oral submucous fibrosis in a 12-year-old Bangladeshi boy: a case report and review of literature

Hazare, V.K.; Goel, R.R.; Gupta, P.C., 1999:
Oral submucous fibrosis, areca nut and pan masala use: a case-control study

Phatak, A.G., 1993:
Oral submucous fibrosis--a chronic disseminated intravascular coagulation syndrome with local coagulopathy

Cox, S.C.; Walker, D.M., 1996:
Oral submucous fibrosis. A review

VanWyk, C.W., 1997:
Oral submucous fibrosis. The South African experience

Regnat, M.; Pernstich, K.P.; Züfle, S.; Ruhstaller, B., 2018:
Analysis of the bias-dependent split emission zone in phosphorescent OLEDs

Aziz, S.R., 1997:
Oral submucous fibrosis: an unusual disease

Cremin, J.D.; Luck, M.L.; Laughlin, N.K.; Smith, D.R., 2001:
Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys

Belka, C., 1998:
Oral sucralfate administration for therapy and prevention of radiation-induced esophagitis: results of a placebo-controlled double-blind study

Tfelt-Hansen, P., 1996:
Oral sumatriptan

Cady, R.K.; Rubino, J.; Crummett, D.; Littlejohn, T.W., 1994:
Oral sumatriptan in the treatment of recurrent headache

O'Connor, P.; Gladstone, P., 1995:
Oral sumatriptan-associated transmural myocardial infarction

Yoshida, S.; Ishibashi, N.; Tajiri, T.; Muraoka, T.; Tanaka, K.; Shirouzu, K., 2001:
Oral supplement of BCAA in patients with liver disease

Nord, C.Erik.; Lidbeck, A.; Orrhage, K.; Sjöstedt, S., 1997:
Oral supplementation with lactic acid-producing bacteria during intake of clindamycin

Schwenk, A.; Steuck, H.; Kremer, G., 2000:
Oral supplements as adjunctive treatment to nutritional counseling in malnourished HIV-infected patients: randomized controlled trial

Potter, J.M., 2000:
Oral supplements in the elderly

Tesoriere, L.; D'Arpa, D.; Butera, D.; Allegra, M.; Renda, D.; Maggio, A.; Bongiorno, A.; Livrea, M.A., 2001:
Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients

Hill, A.S.; Kurkowski, T.B.; Garcia, J., 2000:
Oral support measures used in feeding the preterm infant

Jäger, P., 2000:
Oral surgeons found a society

Anonymous, 1993:
Oral surgeons more likely to treat AIDS patients

Vauthier, T., 1998:
Oral surgery and traumatology in the dental office. II. A report on the SSO congress at Davos of June 11 to 13, 1998. Société Suisse d'Odonto-Stomatologie

Vauthier, T., 1998:
Oral surgery and traumatology in the dental office. The SSO congress at Davos of June 11 to 13, 1998. Société Suisse d'Odonto-Stomatologie

Barry, H.J.; Sleeman, D.; Ryan, C.D.; Allen, F.J., 1996:
Oral surgery at St. Mary's Hospital, Chapelizod. A quarter century experience of day-case oral surgery

O'Dowling, I., 1997:
Oral surgery demands of a regional orthodontic unit

Meechan, J.G.; Welbury, R.R., 1993:
Oral surgery for children: 2. Anaesthesia and sedation

Bader, G.; Mesner, M.; Lejeune, S., 1998:
Oral surgery for liver transplant patients

Leonard, M., 1996:
Oral surgery for the general practitioner. Interview by Phillip Bonner

Leonard, M., 2000:
Oral surgery for the general practitioner: an update. Interview by Phillip Bonner

Souto, J.C.; Oliver, A.; Zuazu-Jausoro, I.; Vives, A.; Fontcuberta, J., 1996:
Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study

Vicente Barrero, M.; Knezevic, M.; Tapia Martín, M.; Viejo Llorente, A.; Orengo Valverde, J.Carlos.; García Jiménez, F.; López Pérez, O.; Domínguez Sarmiento, S.; Díaz Cremades, J.Manuel.; Castellano Reyes, J., 2002:
Oral surgery in patients undergoing oral anticoagulant therapy

Lund, J.P.; Drews, T.; Hetzer, R.; Reichart, P.A., 2003:
Oral surgical management of patients with mechanical circulatory support

Betageri, G.V.; Deshmukh, D.V.; Gupta, R.B., 2001:
Oral sustained-release bioadhesive tablet formulation of didanosine

Tarkkila, L.; Linna, M.; Tiitinen, A.; Lindqvist, C.; Meurman, J.H., 2001:
Oral symptoms at menopause--the role of hormone replacement therapy

Dupuis, L.L.; Armstrong, C., 1998:
Oral syringe for extemporaneously preparing doses

Baldwin, J.N.; Wedemeyer, H.F., 1980:
Oral syringe use survey

Ierardi, E.; Principi, M.; Rendina, M.; Francavilla, R.; Ingrosso, M.; Pisani, A.; Amoruso, A.; Panella, C.; Francavilla, A., 2000:
Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum

Mericske-Stern, R., 1994:
Oral tactile sensibility recorded in overdenture wearers with implants or natural roots: a comparative study. Part 2

Harada, H.; Kitazaki, K.; Tsujino, T.; Watari, Y.; Iwata, S.; Nonaka, H.; Hayashi, T.; Takeshita, T.; Morimoto, K.; Yokoyama, M., 2000:
Oral taurine supplementation prevents the development of ethanol-induced hypertension in rats

Yamamoto, S., 1994:
Oral taurine therapy for painful muscle cramp in liver cirrhosis

Wellington, K.; Goa, K.L., 2002:
Oral tegafur/uracil

Tremlett, M., 1997:
Oral temazepam

Miller, J.L., 1999:
Oral temozolomide approved for refractory brain tumor

Collins, K.J., 1996:
Oral temperature change and cognitive decline in Alzheimer's patients

Robinson, D.; Omar, S.J.; Quach, M.; Yesavage, J.A.; Tinklenberg, J., 1994:
Oral temperature changes and cognitive decline in Alzheimer patients: a possible association

Gowers, D.S.; Carpenter, A.V.; Nash, D.; Ellis, H.M., 1995:
Oral temperatures in a group of healthy industrial workers

Blake, D.W.; Bjorksten, A.R.; Libreri, F.C., 1997:
Oral tenoxicam for peripheral orthopaedic surgery: a pharmacokinetic study

Smith, N.M.; Chambers, S.E.; Billson, V.R.; Laing, I.; West, C.P.; Bell, J.E., 1993:
Oral teratoma (epignathus) with intracranial extension: a report of two cases

Binder, M.; Nell, G., 1999:
Oral terbinafine (Lamisil) in the short-term treatment of fungal infections of the skin: results of a post-marketing surveillance study

Shemer, A.; Weiss, G.; Trau, H., 2002:
Oral terbinafine in the treatment of onychomycosis: a comparison of continuous and extended-pause regimens

L.G.yadec, T.; Saint-Blancard, P.; Bosonnet, S.; L.V.gueresse, R.; Lanternier, G., 2000:
Oral terbinafine-induced plantar pustular psoriasis

Lagace, E., 1997:
Oral terbutaline after parenteral tocolysis

Anonymous, 2001:
Oral test for syphilis

Bartek, J., 1993:
Oral test of magnesium tolerance

Santiago, L.E., 1999:
Oral testimonies: the other face of the HIV story

Gilbert, L., 1994:
Oral testimony of the Association of State and Territorial Dental Directors

Zhao, Y.; Li, Y.; Wang, J.H.; Zhang, J.; Zhang, X., 2018:
Analysis of the binding mode of a novel HIF1α inhibitor through molecular modelling

Hein, H.; Kirsten, D.; Jörres, R.A.; Magnussen, H., 1996:
Oral testing for sulfite asthma

Hong, J.H.; Ahn, T.Y., 2002:
Oral testosterone replacement in Korean patients with PADAM

Schmidt, H.; Knorr, D.; Schwarz, H.P., 1998:
Oral testosterone undecanoate for the induction of puberty in anorchid boys

Mobacken, H., 1993:
Oral tetracycline--treatment of acne. Rapid facial improvement, but back lesions are more difficult to treat

Minthon, L.; Gustafson, L.; Dalfelt, G.; Hagberg, B.; Nilsson, K.; Risberg, J.; Rosén, I.; Seiving, B.; Wendt, P.E., 1993:
Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG

Markwick, A.J.; Rennels, M.B.; Zito, E.T.; Wade, M.S.; Mack, M.E., 1998:
Oral tetravalent rotavirus vaccine can be successfully coadministered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine. US Rhesus Rotavirus Vaccine Study Group

Alhomida, A.S., 2001:
Oral theophylline changes renal carnitine palmitoyltransferase activity in rats

Ram, F.S.; Jones, P.W.; Castro, A.A.; De Brito, J.A.; Atallah, A.N.; Lacasse, Y.; Mazzini, R.; Goldstein, R.; Cendon, S., 2003:
Oral theophylline for chronic obstructive pulmonary disease

Tüzün, B.; Firatli, S.; Tüzün, Y.; Firatli, E.; Wolf, R., 2001:
Oral therapeutics and oral cosmetics

Winston, J.L.; Stewart, J.T., 2000:
Oral therapy for cobalamin deficiency

Damjanov, N.; Meropol, N.J., 2000:
Oral therapy for colorectal cancer: how to choose

Lotz, N., 2002:
Oral therapy in type 2 diabetes. Critical evaluation of glitazones

Trummer, H., 2000:
Oral therapy of erectile dysfunction

Sievert, K.D.; Edenfeld, K.D.; Oberpenning, F.; Piechota, H.J., 2001:
Oral therapy of interstitial cystitis

Salvestrini, F.; Oliva, G.; Mattei, F.M., 1996:
Oral therapy with ciprofloxacin in the prophylaxis of urinary infections in surgical patients with permanent bladder catheter

Desser, L.; Holomanova, D.; Zavadova, E.; Pavelka, K.; Mohr, T.; Herbacek, I., 2001:
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood

Blank, R.D., 1999:
Oral thymic extract to treat hepatitis C

Selvig, K.A.; Biagiotti, G.R.; Leknes, K.N.; Wikesjö, U.M., 1999:
Oral tissue reactions to suture materials

Barker, B.F.; Barker, G.J., 1996:
Oral tobacco use

Choy, E.H., 2001:
Oral toleragens in rheumatoid arthritis

Smith, K.M.; Eaton, A.D.; Finlayson, L.M.; Garside, P., 2000:
Oral tolerance

Garside, P.; Mowat, A.M., 2001:
Oral tolerance

Senesi, B.; Curiale, V.; Lione, L.; Puddu, A.; Pedemonte, A.; Pastorino, A.; Viviani, G.L., 1998:
Oral tolerance and allografts: can multiple oral administrations of low doses of highly purified islets induce peripheral tolerance in pancreatic islet allografts?

Czerkinsky, C.; Sun, J.B.; Holmgren, J., 1999:
Oral tolerance and anti-pathological vaccines

Gale, E.A., 2000:
Oral tolerance and autoimmune diabetes--will hope triumph over experience?

Alpan, O., 2002:
Oral tolerance and gut-oriented immune response to dietary proteins

Hachimura, S.; Kaminogawa, S., 2000 :
Oral tolerance and its clinical application

Weiner, H.L.; Komagata, Y., 1998:
Oral tolerance and the treatment of rheumatoid arthritis

Whitacre, C.C.; Campbell, K.A., 2002:
Oral tolerance as a treatment modality for autoimmune diseases

Thurau, S.R.; Wildner, G., 2002:
Oral tolerance for treating uveitis - new hope for an old immunological mechanism

Gienapp, I.; Cox, K.; Javed, N.; Whitacre, C., 1996:
Oral tolerance in autoimmune encephalomyelitis. In vivo reversal of anergy

Wildner, G.; Thurau, S.R., 2000:
Oral tolerance in autoimmune uveitis

Garside, P.; Mowat, A.M.; Khoruts, A., 1998:
Oral tolerance in disease

Meyer, A.; Gienapp, I.; Cox, K.; Goverman, J.; Hood, L.; Whitacre, C., 1996:
Oral tolerance in myelin basic protein TCR transgenic mice

Wardrop, R.M.; Whitacre, C.C., 1999:
Oral tolerance in the treatment of inflammatory autoimmune diseases

Torigoe, D.Y.; Yoshinari, N.H., 1997:
Oral tolerance in the treatment of rheumatoid arthritis and other autoimmune diseases

Fattal, E.; Couvreur, P.; Pecquet, S., 2002:
Oral tolerance induced by poly (lactide-co-glycolide) containing B lactoglobulin

Yasufuku, K.; Heidler, K.M.; O'Donnell, P.W.; Smith, G.N.; Cummings, O.W.; Foresman, B.H.; Fujisawa, T.; Wilkes, D.S., 2001:
Oral tolerance induction by type V collagen downregulates lung allograft rejection

Sato, M.N.; Oliveira, C.R.; Futata, E.A.; Victor, J.R.; Maciel, M.; Fusaro, A.E.; Carvalho, A.F.; Duarte, A.J.S., 2003:
Oral tolerance induction to Dermatophagoides pteronyssinus and Blomia tropicalis in sensitized mice: occurrence of natural autoantibodies to immunoglobulin E

Lee, H.; Barrett, T.A., 2000:
Oral tolerance therapy in an experimental model of colitis

Blank, M.; George, J.; Barak, V.; Tincani, A.; Koike, T.; Shoenfeld, Y., 1998:
Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome

MacDonald, T.T., 1994:
Oral tolerance. Eating your way towards immunosuppression

Bueno, V.; Pacheco-Silva, A., 1999:
Oral tolerance: a new perspective in the treatment of autoimmune diseases

Ilan, Y., 2000:
Oral tolerance: a new tool for the treatment of gastrointestinal inflammatory disorders and liver-directed gene therapy

Weiner, H.L.; Gonnella, P.A.; Slavin, A.; Maron, R., 1998:
Oral tolerance: cytokine milieu in the gut and modulation of tolerance by cytokines

Fowler, E.; Weiner, H.L., 1997:
Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases

Weiner, H.L.; Mayer, L.F., 1996:
Oral tolerance: mechanisms and applications. Introduction

Epstein, J.B.; Truelove, E.L.; Oien, H.; Allison, C.; Le, N.D.; Epstein, M.S., 2001:
Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy

Gelderblom, H.A.; D.J.nge, M.J.; Sparreboom, A.; Verweij, J., 2000:
Oral topoisomerase 1 inhibitors in adult patients: present and future

Gerrits, C.J.; Burris, H.; Schellens, J.H.; Eckardt, J.R.; Planting, A.S.; van der Burg, M.E.; Rodriguez, G.I.; Loos, W.J.; van Beurden, V.; Hudson, I.; Fields, S.; Von Hoff, D.D.; Verweij, J., 1998:
Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors

Patterson, J.H.; Adams, K.F.; Applefeld, M.M.; Corder, C.N.; Masse, B.R., 1994:
Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators Group

Rose, J.B.; Finkel, J.C.; Arquedas-Mohs, A.; Himelstein, B.P.; Schreiner, M.; Medve, R.A., 2002:
Oral tramadol for the treatment of pain of 7-30 days' duration in children

Wilder-Smith, C.H.; Schimke, J.; Osterwalder, B.; Senn, H.J., 1994:
Oral tramadol, a mu-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain

Ridley, R.M.; Baker, H.F., 1996:
Oral transmission of BSE to primates

Dutta, J.K., 1996:
Oral transmission of rabies in cow: milk consumers protected by immunisation

Prosser, D.; Allman, M.; Grassby, P., 1999:
Oral transmucosal fentanyl

Gardner-Nix, J., 2001:
Oral transmucosal fentanyl and sufentanil for incident pain

Anonymous, 1994:
Oral transmucosal fentanyl citrate

Borgbjerg, F.M.; Rosenberg, J., 2000:
Oral transmucosal fentanyl citrate (OTFC) in the treatment of breakthrough pain

Howell, T.K., 2001:
Oral transmucosal fentanyl citrate as a premedicant

Konen, A.; Flanagan, B.; Hanley, S.; Salinas, R.; Ramsay, M.A.; Ramsay, K.J., 1997:
Oral transmucosal fentanyl citrate as an additional premedicant for adult cardiac surgery patients

Ginsberg, B.; Dear, R.B.; Margolis, J.O.; Dear, G.D.; Ross, A.K., 1998:
Oral transmucosal fentanyl citrate as an anaesthetic premedication when dosed to an opioid effect vs total opioid consumption

Friesen, R.H.; Carpenter, E.; Madigan, C.K.; Lockhart, C.H., 1995:
Oral transmucosal fentanyl citrate for preanaesthetic medication of paediatric cardiac surgery patients

Chandler, S., 1999:
Oral transmucosal fentanyl citrate: a new treatment for breakthrough pain

Moore, P.A.; Cuddy, M.A.; Magera, J.A.; Caputo, A.C.; Chen, A.H.; Wilkinson, L.A., 2002:
Oral transmucosal fentanyl pretreatment for outpatient general anesthesia

Anonymous, 2002:
Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails

Cioacă, R.; Canavea, I., 1996:
Oral transmucosal ketamine: an effective premedication in children

Müller-Driver, O., 1996:
Oral transmuscular adenoma removal of the submandibular gland

Cunha, R.F.; Pugliesi, D.M.; de Mello Vieira, A.E., 2001:
Oral trauma in Brazilian patients aged 0-3 years

Anonymous, 2001:
Oral treatment for KS

Josefson, D., 1998:
Oral treatment for hepatitis B gets approval in the United States

Altay, C.; Cetin, M., 1997:
Oral treatment in selective vitamin B12 malabsorption

Anonymous, 1999:
Oral treatment of acne. Agence Française de Securité Sanitaire des Produits de Santé

Guirguis, W.R., 1998:
Oral treatment of erectile dysfunction: from herbal remedies to designer drugs

Loughlin, K.A.; Bakst, C.M.; Rybak, M.J., 1994:
Oral treatment of gonorrhea and chlamydia

Gasser, R.; Reisinger, E.; Sedaj, B.; Horvarth, R.; Seinost, G.; Keplinger, A.; Wendelin, I.; Klein, W., 1996:
Oral treatment of late Lyme borreliosis with a combination of roxithromycin and co-trimoxazole--a pilot study on 18 patients

Ellis, M.R.; Kane, K.Y., 1999:
Oral treatment of onychomycosis

Bergman, W.; Rutten, F.F., 1994:
Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine

Zimecki, M.; Miedzybrodzki, R.; Szymaniec, S., 1999:
Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production

Sundar, S.; Gupta, L.B.; Makharia, M.K.; Singh, M.K.; Voss, A.; Rosenkaimer, F.; Engel, J.; Murray, H.W., 2000:
Oral treatment of visceral leishmaniasis with miltefosine

Riley, A., 1996:
Oral treatments for erectile dysfunction

Brosnan, R., 2002:
Oral treatments for type II diabetes in patients with cardiovascular disease

Keldsen, N.; Madsen, E.L.; Havsteen, H.; Kamby, C.; Laursen, L.; Sandberg, E., 1998:
Oral treosulfan as second-line treatment in platinum-resistant ovarian cancer: a phase II study. The Danish Ovarian Cancer Study Group

Stopperich, P.S.; Moore, P.A.; Finder, R.L.; McGirl, B.E.; Weyant, R.J., 1993:
Oral triazolam pretreatment for intravenous sedation

Labenz, J.; Gyenes, E.; Rühl, G.H.; Börsch, G., 1993:
Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease

Reichardt, P.; Pink, D.; Tilgner, J.; Kretzschmar, A.; Thuss-Patience, P.C.; Dörken, B., 2003 :
Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis

Roy, S.; Hemsell, D.; Gordon, S.; Godwin, D.; Pearlman, M.; Luke, D., 1999:
Oral trovafloxacin compared with intravenous cefoxitin in the prevention of bacterial infection after elective vaginal or abdominal hysterectomy for nonmalignant disease. Trovafloxacin Surgical Group

Mignogna, M.D.; Muzio, L.L.; Favia, G.; Ruoppo, E.; Sammartino, G.; Zarrelli, C.; Bucci, E., 2000:
Oral tuberculosis: a clinical evaluation of 42 cases

Buonomo, S.; Legrand, W.; Magremanne, M., 1996:
Oral tuberculosis: apropos of a case

Kaye, S.B., 1999:
Oral tumoractivated chemotherapy--an introduction

Maaita, J.K., 2001:
Oral tumors in children: a review

Kalyanyama, B.M.; Matee, M.I.N.; Vuhahula, E., 2002:
Oral tumours in Tanzanian children based on biopsy materials examined over a 15-year period from 1982 to 1997

Field, E.A.; Ellis, A.; Friedmann, P.S.; Leigh, I.M.; Field, J.K., 1997:
Oral tylosis: a re-appraisal

Cazzola, M.; Antivalle, M.; Sarzi-Puttini, P.; Dell'Acqua, D.; Panni, B.; Caruso, I., 2000:
Oral type II collagen in the treatment of rheumatoid arthritis. A six-month double blind placebo-controlled study

Hajee, M.A.; Aleem, 1993:
Oral typhoid vaccine

Mazzone, T.; Celestini, E.; Fabi, R.; Pagano, M.; Serafini, M.A.; Verdecchia, P.; Mastroiacovo, P., 1994:
Oral typhoid vaccine and pregnancy

Berlin, I.; Molinier, P., 1993:
Oral tyramine challenge tests

Piattelli, A.; Favia, G.F.; D.A.berti, L., 1998:
Oral ulceration as a presenting sign of unknown sarcoidosis mimicking a tumour: report of 2 cases

MacPhail, L.A.; Greenspan, J.S., 1997:
Oral ulceration in HIV infection: investigation and pathogenesis

Quail, G.G., 1994:
Oral ulceration. Things are not always what they seem

Reichart, P.A., 1997:
Oral ulcerations in HIV infection

Morrow, J.D., 1999:
Oral ulcerations in a patient with sarcoidosis

Kademani, D.; Glick, M., 1998:
Oral ulcerations in individuals infected with human immunodeficiency virus: clinical presentations, diagnosis, management, and relevance to disease progression

Salisbury, P.L.; Jorizzo, J.L., 1993:
Oral ulcers and erosions

Paleri, V.; Lindsey, L., 2001:
Oral ulcers caused by hydroxyurea

Bassetti, S.; Courvoisier, S.; Itin, P., 1997 :
Oral ulcers in HIV infection

Ficarra, G., 1997:
Oral ulcers in HIV-infected patients: an update on epidemiology and diagnosis

Marquart-Elbaz, C.; Lipsker, D.; Grosshans, E.; Cribier, B., 1999:
Oral ulcers induced by nicorandil: prevalence and clinicopathological aspects

Maroto, M.R., 1996:
Oral ulcers of infants in 16th century Spanish medical texts

Jones, R.; Twelves, C., 2001:
Oral uracil-tegafur: an alternative to intravenous 5-fluorouracil?

Chen, S.C.; Chang, K.J.; Lee, P.H.; Wang, S.M.; Chen, K.M.; Lin, F.Y., 1999:
Oral urografin in postoperative small bowel obstruction

White, J.R.; Kramer, J.; Campbell, R.K.; Bernstein, R., 1994:
Oral use of a topical preparation containing an extract of Stevia rebaudiana and the chrysanthemum flower in the management of hyperglycemia

Palomba, M.; Melis, G.B., 2000:
Oral use of interferon therapy in cervical human papillomavirus infection

Mydlík, M.; Derzsiová, Kína.; Boldizsár, Ján.; Hríbiková, Mária.; Petrovicová, Jína., 2003:
Oral use of iron with vitamin C in hemodialyzed patients

Roberts, M.; Li, J.; Bacon, A.; Chatfield, S., 1998:
Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters

Anonymous, 2000:
Oral vaccine tested

Levine, M.M., 1997:
Oral vaccines against cholera: lessons from Vietnam and elsewhere

Fescharek, R.; Arras-Reiter, C.; Arens, E.R.; Quast, U.; Maass, G., 1997:
Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?

Liesveld, J.L.; Abboud, C.N.; Ifthikharuddin, J.J.; Lancet, J.E.; Wedow, L.A.; Oliva, J.; Stamm, C.G.; Nichols, D., 2003:
Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients

Reusser, P., 2002:
Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts

Madsen, K.L.; Porter, V.M.; Fedorak, R.N., 1993:
Oral vanadate reduces Na(+)-dependent glucose transport in rat small intestine

McNeill, J.H.; Battell, M.; Cam, M.; Dai, S.; Thompson, K.; Yuen, V., 1994:
Oral vanadium and lowering of blood glucose

Damjanovic, V.; van Saene, H.K.; Cooke, R.W.; Pierro, A., 1993:
Oral vancomycin in staphylococcal septicaemia of bowel origin in neonates

Miteva, L.G.; Dourmishev, A.I.; Schwartz, R.A.; Mitev, V.I., 1998:
Oral vascular manifestations of Klippel-Trénaunay syndrome

Pérez-Olea, J., 1996:
Oral vasodilators in the treatment of congestive heart failure

Bu, J.; Shi, H.; Hu, M.; Liu, H., 2002:
Oral venous lakes: a clinicopathologic analysis of 20 cases

Millward, M.J.; Cantwell, B.M.; Munro, N.C.; Robinson, A.; Corris, P.A.; Harris, A.L., 1993:
Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study

Chen, Y-Kwan.; Hsue, S-Shan.; Lin, L-Min.; Lin, C-Chung.; Terezhalmy, G.T.; Riley, C.K.; Moore, W.S., 2002:
Oral verruca vulgaris

Barasch, A.; Eisenberg, E.; D'Ambrosio, J.A.; Nuki, K.; Peterson, D.E., 1996:
Oral verruca vulgaris in a bone marrow transplant patient: a case report and review of literature

Blazys, D., 2002:
Oral versus IV steroids for asthma

Agrawal, M.; French, L., 1999:
Oral versus i.v. steroids for children hospitalized with asthma

Athaullah, N.; Proctor, M.; Johnson, N.P., 2002:
Oral versus injectable ovulation induction agents for unexplained subfertility

Watson, M.C.; Grimshaw, J.M.; Bond, C.M.; Mollison, J.; Ludbrook, A., 2002:
Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review

Ravelli, A.; Gerloni, V.; Corona, F.; Falcini, F.; Lepore, L.; D.S.nctis, R.; Zulian, F.; Buoncompagni, A.; Sardella, M.L.; Strano, C.G.; Alessio, M.; Fantini, F.; Bardare, M.; Martini, A., 1998:
Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group

Beck, R.W., 1997:
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis

Tremlett, H., 1997:
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis

Kern, W.V.; Cometta, A.; D.B.ck, R.; Langenaeken, J.; Paesmans, M.; Gaya, H., 1999:
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

Mayer, R.J., 2001:
Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same

Johnson, D.W.; Herzig, K.A.; Gissane, R.; Campbell, S.B.; Hawley, C.M.; Isbel, N.M., 2002:
Oral versus intravenous iron supplementation in peritoneal dialysis patients

Kamen, B.A.; Winick, N.; Holcenberg, J.S., 1998:
Oral versus intravenous methotrexate: another opinion

de Oliveira Becci, A.Carolina.; Marti, L.Mafra.; Cilense Zuanon, A.Cristina.; Brighenti, F.Lourenço.; Palomari Spolidório, D.Madalena.; Aparecida Giro, E.Maria., 2017:
Analysis of the biofilm formed on the surface of a glass-ionomer cement associated with different concentrations of chlorhexidine diacetate

Swanepoel, A.; Semple, P., 1999:
Oral versus rectal diclofenac for postoperative tonsillectomy pain in children

Jensen, B.; Matsson, L., 2002:
Oral versus rectal midazolam as a pre-anaesthetic sedative in children receiving dental treatment under general anaesthesia

Park, S.Pyo.; Tak, Y.Jun.; Kim, H.Jun.; Lee, J.Hyeok.; Yoo, H.; Kim, H.Jae., 2018:
Analysis of the Bipolar Resistive Switching Behavior of a Biocompatible Glucose Film for Resistive Random Access Memory

Stevenson, J.C.; Crook, D.; Godsland, I.F.; Lees, B.; Whitehead, M.I., 1993:
Oral versus transdermal hormone replacement therapy

Bower, D.J.; Meurer, L.N., 1999:
Oral versus vaginal administration of misoprostol for labor induction

Barik, S.; Stewart, P., 1997:
Oral versus vaginal misoprostol for cervical priming

Carbonell, J.L.; Velazco, A.; Rodriguez, Y.; Tanda, R.; Sánchez, C.; Barambio, S.; Valera, L.; Chami, S.; Valero, F.; Aragón, S.; Marí, J., 2002:
Oral versus vaginal misoprostol for cervical priming in first-trimester abortion: a randomized trial

Cannon, B.J.; Thaler, T.; Roos, S., 2002:
Oral versus written administration of the Geriatric Depression Scale

Steffen, G.E., 1994:
Oral versus written approval--a cautionary note

Elnicki, D.M.; Layne, R.D.; Ogden, P.E.; Morris, D.K., 1998:
Oral versus written feedback in medical clinic

Fucci, D.; Petrosino, L., 1995:
Oral vibrotactile assessment procedures: modifications

Pérez-Cuadrado, E.; Lamas García, D.; Robles Reyes, A., 1996:
Oral video enteroscopy: a prospective study of 30 cases

Bărlean, L., 1993:
Oral villous leukoplakia, a new clinico-pathological entity

Vokes, E.E.; Rosenberg, R.; Jahanzeb, M.; Craig, J.; Gralla, R.; Belani, C.; Jones, S.; Bigley, J.; Hohneker, J., 1994:
Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report

Marty, M.; Fumoleau, P.; Adenis, A.; Rousseau, Y.; Merrouche, Y.; Robinet, G.; Senac, I.; Puozzo, C., 2002:
Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors

Anonymous, 1997:
Oral vinorelbine promising and well tolerated in patients with advanced breast cancer

Depierre, A.; Freyer, G.; Jassem, J.; Orfeuvre, H.; Ramlau, R.; Lemarie, E.; Koralewski, P.; Mauriac, L.; Breton, J.L.; Delozier, T.; Trillet-Lenoir, V., 2002:
Oral vinorelbine: feasibility and safety profile

Cobcroft, R.; Cobcroft, S., 1999:
Oral vitamin B12 for B12 deficiency

Kearns, S.R.; Moneley, D.; Murray, P.; Kelly, C.; Daly, A.F., 2002:
Oral vitamin C attenuates acute ischaemia-reperfusion injury in skeletal muscle

Argilés, A.; Mourad, G.; Mion, C., 1996:
Oral vitamin D or calcium carbonate in the prevention of renal bone disease?

Watanabe, Y.; Inaguma, D.; Fukuzawa, Y.; Kumon, S.; Yamazaki, C., 1996:
Oral vitamin D3 pulse therapy for overt secondary hyperparathyroidism at pre-dialysis stage

Olson, P.E.; Torp, E.C.; Mahon, R.T.; Weiss, P.J.; Wallace, M.R., 1994:
Oral vitamin E for refractory hand dermatitis

Joubert, P.H.; Stoeckel, K., 1994:
Oral vitamin K in breast-fed infants to prevent late haemorrhagic disease of the newborn

Barton, J.S.; McNinch, A.W.; Tripp, J.H., 1994:
Oral vitamin K prophylaxis and frequency of late vitamin K deficiency bleeding

von Kries, R.; Göbel, U., 1994:
Oral vitamin K prophylaxis and late haemorrhagic disease of the newborn

Baenziger, O.; Braegger, C.P.; Fanconi, S., 1996:
Oral vitamin K prophylaxis for newborn infants: safe enough?

Laupacis, A., 2003:
Oral vitamin K reversed warfarin-associated coagulopathy faster than subcutaneous vitamin K

Pereira, A.M.; Hamani, N.; Nogueira, P.C.; Carvalhaes, J.T., 2000:
Oral vitamin intake in children receiving long-term dialysis

Margo, K.; Shaughnessy, A.F., 1997:
Oral vs i.v. steroids for asthma

Felefli, S.; Flaitz, C.M., 2001:
Oral warts in HIV-infected individuals

Leigh, J., 2002:
Oral warts rise dramatically with use of new agents in HIV

Axéll, T.; Pindborg, J.J.; Smith, C.J.; van der Waal, I., 1996:
Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions

Chang, C-Jung.; Huang, L-Tung.; Lui, C-Chung.; Huang, S-Chei., 2002:
Oral wooden stick injury complicated by meningitis and brain abscess

Takata, T., 1994:
Oral wound healing concepts in periodontology

Blignaut, E.; Raubenheimer, E.; van Heerden, W.F.; Senekal, R.; Dreyer, M.J., 1995:
Oral yeast flora of a Kalahari population

Bhadrakom, C.; Simonds, R.J.; Mei, J.V.; Asavapiriyanont, S.; Sangtaweesin, V.; Vanprapar, N.; Moore, K.H.; Young, N.L.; Hannon, W.H.; Mastro, T.D.; Shaffer, N., 2000:
Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group

Reich, E.N.; Church, J.A., 1994:
Oral zinc supplementation in the treatment of HIV-infected children

Gupta, R.; Garg, V.K.; Mathur, D.K.; Goyal, R.K., 2001:
Oral zinc therapy in diabetic neuropathy

Mahajan, P.M.; Jadhav, V.H.; Patki, A.H.; Jogaikar, D.G.; Mehta, J.M., 1994:
Oral zinc therapy in recurrent erythema nodosum leprosum: a clinical study

Regli, F.; Nater, B., 2000:
Oral zolmitriptan (Zomig) in the treatment of migraine crisis

Bircher, A.J.; Rutishauser, M., 1998:
Oral "desensitization" of maculopapular exanthema from ciprofloxacin

Ferraris, S., 1998:
Oral, cardiovascular and general health

Keutel, C.; Vees, B.; Krimmel, M.; Cornelius, C.P.; Schwenzer, N., 1997:
Oral, facial and cranial manifestations of von Recklinghausen neurofibromatosis (NF)

French, S.J.; Cecil, J.E., 2002:
Oral, gastric and intestinal influences on human feeding

Savarino, S.J.; Hall, E.R.; Bassily, S.; Brown, F.M.; Youssef, F.; Wierzba, T.F.; Peruski, L.; El-Masry, N.A.; Safwat, M.; Rao, M.; E.M.hamady, H.; Abu-Elyazeed, R.; Naficy, A.; Svennerholm, A.M.; Jertborn, M.; Lee, Y.J.; Clemens, J.D., 1998:
Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group

Escuder, O.; Pericot, J.; Piulachs, P.; Biosca, J.; Garcia-Rozado, A.; Gimeno, J.; Monner, A., 1998:
Oral, mandibular and oropharyngeal reconstruction with a pedicled trapezius flap

Cundy, K.C.; Shaw, J.P.; Lee, W.A., 1994:
Oral, subcutaneous, and intramuscular bioavailabilities of the antiviral nucleotide analog 9-(2-phosphonylmethoxyethyl) adenine in cynomolgus monkeys

Anonymous, 2001:
Oral, tongue cancer rates rise among young Americans

Langius, A.; Björvell, H.; Lind, M.G., 1993:
Oral- and pharyngeal-cancer patients' perceived symptoms and health

Dogliotti, P.; Nadal, E.; Ulfe, I., 1998:
Oral-acral syndrome and its correction using maxillary bone distraction osteogenesis

Risch, H.A., 2000:
Oral-contraceptive use, anovulatory action, and risk of epithelial ovarian cancer

Tapsoba, H.; Deschamps, J.P., 1998:
Oral-dental health in the national health system of Burkina Faso

Alvarez González, J.; Cala Cordero, J.; Piñera Palacio, C.; Rubio Domínguez, J.; Molejón Iglesias, A., 1994:
Oral-dental hygiene in schoolchildren. Knowledge and prevention

Mojon, P., 1998:
Oral-dental situation in elderly persons: a public health problem

D.Troyer, J., 2000:
Oral-dental treatment strategies in the aging patient

Rojas de Morales, T.; Zambrano, O.; Rivera, L.; Navas, R.; Chaparro, N.; Bernardonni, C.; Rivera, F.; Fonseca, N.; Tirado, D.M., 2001:
Oral-disease prevention in children with cancer: testing preventive protocol effectiveness

Barton, D.H.; Henderson, H.Z., 1993:
Oral-facial characteristics of circumscribed scleroderma: case report

Gillcrist, J.A.; Brumley, D.E., 1999:
Oral-facial sports injuries

Morán-Barroso, V.; Valdés Flores, M.; García-Cavazos, R.; Kofman-Alfaro, S.; Saavedra-Ontiveros, D., 1998:
Oral-facial-digital (OFD) syndrome with associated features: a new syndrome or genetic heterogeneity and variability?

Steichen-Gersdorf, E.; Gassner, I.; Covi, B.; Fischer, H., 1994:
Oral-facial-digital syndrome II. Transitional type between Mohr and Majewski syndrome: report of a new case with congenital stenosis of the trachea

Jamieson, R.; Collins, F., 1993:
Oral-facial-digital syndrome and retinal abnormalities with autosomal recessive inheritance

Sakai, N.; Nakakita, N.; Yamazaki, Y.; Ui, K.; Uchinuma, E., 2002:
Oral-facial-digital syndrome type II (Mohr syndrome): clinical and genetic manifestations

Phadke, S.R.; Pahi, J.; Pandey, A.; Agarwal, S.S., 1999:
Oral-facial-digital syndrome with acromelic short stature: a new variant--overlap with Ellis Van Creveld syndrome

Sigaudy, S.; Philip, N.; Gire, C.; Chabrol, B., 1996:
Oral-facial-digital syndrome with retinal abnormalities: report of a new case

Toriello, H.V., 1993:
Oral-facial-digital syndromes, 1992

Naritomi, K., 2001:
Oral-facial-skeletal syndrome

Neri, G.; Gurrieri, F.; Genuardi, M., 1995:
Oral-facial-skeletal syndromes

Beiruti, N.; Tayfour, D.; Boles, W.; Poulsen, S., 1995:
Oral-health-related knowledge and behaviour of a group of 15-year-old school-children from Damascus, Syria

Mathisen, B.A.; Shepherd, K., 1997:
Oral-motor dysfunction and feeding problems in infants with myelodysplasia

Nakata, Y.; Niimi, Y., 1995:
Oral-to-nasal endotracheal tube exchange in patients with bleeding esophageal varices

Kenady, D.E.; Arnold, S.M.; Regine, W.F.; Mentzer, R.M., 2002:
Oral/pharyngeal squamous carcinoma: treatment strategies

Fedele, D.J.; Jones, J.A.; Niessen, L.C.; Guo, I.Y.; Harrison, K., 1999:
Oral/pharyngeal, laryngeal, and lung cancer discharge trends in Department of Veterans Affairs hospitals

Anonymous, 1996:
Oralet (oral transmucosal fentanyl lozenges)

Leavens, G.J., 1996:
Oralife

Brookfield, J.R., 1996:
Oralife managed care plan is a no go

Koschinsky, T.; He, C.J.; Mitsuhashi, T.; Bucala, R.; Liu, C.; Buenting, C.; Heitmann, K.; Vlassara, H., 1997:
Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy

Kitamura, S.; Fukushi, I.; Miyawaki, T.; Kawamura, M.; Terashita, E.; Naka, T., 2001:
Orally active GPIIb/IIIa antagonists: synthesis and biological activities of masked amidines as prodrugs of 2-[(3S)-4

Sonesson, C.; Boije, M.; Svensson, K.; Ekman, A.; Carlsson, A.; Romero, A.G.; Martin, I.J.; Duncan, J.N.; King, L.J.; Wikström, H., 1993:
Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo

Kume, M.; Kubota, T.; Kimura, Y.; Nakashimizu, H.; Motokawa, K.; Nakano, M., 1993:
Orally active cephalosporins. II. Synthesis and structure-activity relationships of new 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-cephalospori ns with 1,2,3-triazole in C-3 side chain

Kume, M.; Kubota, T.; Kimura, Y.; Nakashimizu, H.; Motokawa, K., 1993:
Orally active cephalosporins. III. Synthesis and structure-activity relationships of new 3-heterocyclicthiomethylthio-7 beta-[(Z)- 2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-cephem-4 -carboxylic acids

Yamamoto, H.; Terasawa, T.; Nakamura, A.; Kawabata, K.; Sakane, K.; Matsumoto, S.; Matsumoto, Y.; Tawara, S., 2000:
Orally active cephalosporins. Part 2: synthesis, structure-activity relationships and oral absorption of cephalosporins having a C-3 pyridyl side chain

Yamamoto, H.; Terasawa, T.; Nakamura, A.; Kawabata, K.; Takasugi, H.; Tanaka, H.; Matsumoto, S.; Matsumoto, Y.; Tawara, S., 2001:
Orally active cephalosporins. Part 3: synthesis, structure-activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporins

Yamamoto, H.; Terasawa, T.; Ohki, A.; Shirai, F.; Kawabata, K.; Sakane, K.; Matsumoto, S.; Matsumoto, Y.; Tawara, S., 2000:
Orally active cephalosporins: synthesis, structure-activity relationships and oral absorption of 3-[(E) and (Z)-2-substituted vinyl]-cephalosporins

Patchett, A.A.; Smith, R.G.; Wyvratt, M.J., 1998:
Orally active growth hormone secretagogues

Pineo, G.F.; Hull, R.D.; Marder, V.J., 2001:
Orally active heparin and low-molecular-weight heparin

Hulme, C.; Mathew, R.; Moriarty, K.; Miller, B.; Ramanjulu, M.; Cox, P.; Souness, J.; Page, K.M.; Uhl, J.; Travis, J.; Labaudiniere, R.; Huang, F.; Djuric, S.W., 1999:
Orally active indole N-oxide PDE4 inhibitors

Olivieri, N.F., 1996:
Orally active iron chelators in the treatment of iron overload

Eldred, C.D.; Evans, B.; Hindley, S.; Judkins, B.D.; Kelly, H.A.; Kitchin, J.; Lumley, P.; Porter, B.; Ross, B.C.; Smith, K.J., 1994:
Orally active non-peptide fibrinogen receptor (GpIIb/IIIa) antagonists: identification of 4-[4-[4-(aminoiminomethyl)phenyl]-1-piperazinyl]-1-piperidineacetic acid as a long-acting, broad-spectrum antithrombotic agent

Sugg, E.E.; Birkemo, L.; Gan, L.S.; Tippin, T.K., 1998:
Orally active nonpeptide CCK-A agonists

Dickson, J.K.; Biller, S.A.; Magnin, D.R.; Petrillo, E.W.; Hillyer, J.W.; Hsieh, D.C.; Lan, S.J.; Rinehart, J.K.; Gregg, R.E.; Harrity, T.W.; Jolibois, K.G.; Kalinowski, S.S.; Kunselman, L.K.; Mookhtiar, K.A.; Ciosek, C.P., 1996:
Orally active squalene synthase inhibitors: bis((acyloxy)alkyl) prodrugs of the alpha-phosphonosulfonic acid moiety

Hurley, T.R.; Colson, C.E.; Hicks, G.; Ryan, M.J., 1993:
Orally active water-soluble N,O-acyl transfer products of a beta,gamma-bishydroxyl amide containing renin inhibitor

Ogawa, H.; Yamashita, H.; Kondo, K.; Yamamura, Y.; Miyamoto, H.; Kan, K.; Kitano, K.; Tanaka, M.; Nakaya, K.; Nakamura, S.; Mori, T.; Tominaga, M.; Yabuuchi, Y., 1996:
Orally active, nonpeptide vasopressin V2 receptor antagonists: a novel series of 1-[4-(benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and related compounds

Litzman, J.; Lokaj, J.; Gerylovova, A., 1996:
Orally administered bacterial lysate Broncho-Vaxom for the treatment of common variable immunodeficiency

Wietlispach Claussen, D., 1993:
Orally administered gallbladder therapeutic agents, Part 1: Chenix (chenodeoxycholic acid, CDCA)

Claussen, D.W., 1993:
Orally administered gallbladder therapeutic agents, Part II: Actigall (ursodeoxycholic Acid, UDCA)

Gonze, M.D.; Manord, J.D.; Leone-Bay, A.; Baughman, R.A.; Garrard, C.L.; Sternbergh, W.C.; Money, S.R., 1998:
Orally administered heparin for preventing deep venous thrombosis

Dusková, M.; Wald, M., 1999:
Orally administered proteases in aesthetic surgery

Cossu, M.L.; Caccia, S.; Coppola, M.; Fais, E.; Ruggiu, M.; Fracasso, C.; Nacca, A.; Noya, G., 1999:
Orally administered ranitidine plasma concentrations before and after biliopancreatic diversion in morbidly obese patients

Malshe, P.C., 2001:
Orally administered serratiopeptidase: can it work?

Musabayane, C.T.; Munjeri, O.; Bwititi, P.; Osim, E.E., 1999:
Orally administered, insulin-loaded amidated pectin hydrogel beads sustain plasma concentrations of insulin in streptozotocin-diabetic rats

Bradbury, J., 2002:
Orally available cidofovir derivative active against smallpox

Richardson, D.R.; Ponka, P., 1998:
Orally effective iron chelators for the treatment of iron overload disease: the case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs

Gutgesell, C.; Fuchs, T., 2002:
Orally elicited allergic contact dermatitis to tetraethylthiuramdisulfide

Neely, J.G.; Nelson, R.A., 1994:
Orally ingested nystatin powder in water for the stabilization of hearing in patients with fluctuating hearing loss

Brookes, S.J.; Meedeniya, A.C.; Jobling, P.; Costa, M., 1998:
Orally projecting interneurones in the guinea-pig small intestine

Adami; Gandolfo; Esposito; Scopinaro, 1991 :
Orally-administered Serum Ranitidine Concentration after Biliopancreatic Diversion for Obesity

Nakane, S.; Kakumoto, M.; Yukimatsu, K.; Chien, Y.W., 1996:
Oramucosal delivery of LHRH: pharmacokinetic studies of controlled and enhanced transmucosal permeation